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A b s t r a c t
Expanded bed adsorption (EBA) combines clarification, concentration 
and purification into a single processing step reducing processing time 
and increasing productivity. Much work has been conducted on model 
proteins but little attention has been paid to the emerging issues of 
tailoring the operational variables of matrix size, operating flowrate and 
ligand type so as to maximise process outputs. The aims of this study 
were to investigate the effects of matrix properties and operating 
parameters on breakthrough behaviour and productivity. Second 
generation matrices designed to operate at high flowrates were also 
examined.
Operating at low velocities, beds formed from smaller particles had a 
shallower breakthrough than beds formed from large particles but the 
latter were more productive. At the higher velocities typically utilised in 
EBA, the behaviour of beds formed from either small or large particles 
was comparable in terms of breakthrough with the beds made up of 
small particles being slightly more productive than those containing large 
particles.
A prototype 2nd generation EBA matrix consisting of a multi-modal 
ligand that could operate at high conductivity levels typical of 
fermentation broths was also examined. It was found that the 
productivity could be increased 5-fold as compared with commercially 
available matrices, with no loss of yield or purity.
Conventional breakthrough curve analysis is not applicable in situations 
of variable particle size and operating velocity. Results using a novel 
dimensionless group to facilitate comparison between unlike systems is 
presented.
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Abstract
The thesis presents an analysis of the relative productivity of a range of 
systems and highlights the gains in terms of productivity to be achieved 
with the development of 2nd generation EBA multi-modal adsorbents. 
The thesis concludes with an analysis of the commercial and regulatory 
aspects of EBA.
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l  In t r o d u c t io n
1.1 Introduction to the Engineering Doctorate
There were two main aims of the Engineering Doctorate (EngD) that was 
carried out in collaboration w ith Amersham Biosciences (now part of GE 
Healthcare):
1. To complete a research project of industrial relevance.
2. To develop skills appropriate to the working environment, in 
particular management and validation of bioprocesses, through a 
series of taught courses, examinations and work experience.
The research project that was agreed with Amersham Biosciences 
concentrated on the effects of matrix properties and operating parameters 
on the breakthrough behaviour and overall productivity of an expanded 
bed adsorption (EBA) step. In addition, Amersham Biosciences, at the 
time of this research, were in the process of developing second generation 
EBA matrices and columns that are now available commercially 
(STREAMLINE™ Direct columns and adsorbents). Work on some of 
these prototype matrices formed part of the research and were also the 
basis of the management project.
The bulk of this thesis is a description of the results and conclusions of 
the research carried out. In addition, as part of the EngD requirements, a 
description of the project m anagement of a research and development 
(R&D) project is provided in Chapter 11 and the validation issues 
surrounding EBA are provided in Chapter 12.
This chapter will give an overview of EBA, including the traditional 
processing steps of a protein, general chromatography theory, and the 
development and operation of EBA.
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1.2 Introduction to Expanded Bed Adsorption
The production of recombinant proteins for use in the treatm ent and 
prevention of diseases has increased dramatically in the last decade. 
Processing of these types of product, especially those proteins aimed for 
therapeutic use can require num erous steps, thus reducing product yields 
and increasing processing time. Processing strategies that can reduce the 
overall number of steps are an attractive and efficient solution to this type 
of challenge. EBA is such a solution as it combines clarification, 
concentration and purification into one processing step that can be 
employed early on in downstream  processing. As such, processing times 
and hence the risk of product degradation are reduced and yields are 
increased by the use of EBA.
1.3 Traditional Processing Steps
Purification of recombinant proteins can essentially be divided into 3 
stages (Protein Purification Handbook):
1. Capture
2. Intermediate Purification
3. Polishing
The capture step clarifies and concentrates the feedstock from the 
bioreactor. This is usually achieved by centrifugation a n d /o r  
microfiltration to clarify, and either some adsorptive technique or 
ultrafiltration to concentrate. Clarification is crucial in order to apply the 
feedstock to a packed bed chromatography column and concentration 
can reduce processing time of the intermediate purification step. 
Expanded bed adsorption is used to replace all stages within the capture 
step.
Intermediate purification is used to remove the bulk of the contaminating 
proteins and impurities and is usually carried out in packed bed
22
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chromatography. The most common type of chromatography at this stage 
is ion exchange (IEX), however hydrophobic interaction (HIC), 
immobilised metal affinity (IMAC) and affinity chromatography may be 
employed
The final polishing stages are to remove small amounts of impurities. 
This is usually achieved by IEX, gel filtration a n d /o r reversed phase 
chrom atography.
1.4 General Chromatographic Theory
Chromatography describes many different processes in both the chemical 
and biological fields. The broadest definition would be to say that 
chromatography is the separation of a substance (or substances) from a 
mobile phase by attachment onto a stationary phase. Separation of 
coloured dyes on filter paper by speed of travel is perhaps the simplest 
form of chromatography, and is known as one-dimensional 
chromatography. It is this principle that is still used for purification of 
proteins in biotechnology. The addition of a second "dimension" results 
in the mobile phase passing through a stationary column of adsorbent, 
where the cross-section of the column represents the second dimension. 
Most chemical and biological chromatographic purifications utilise a 
column of adsorbent or matrix of some kind and so are classed as two- 
dimensional chromatography. Two-dimensional chromatography has the 
major advantage of being able to handle large quantities of mobile phase.
Products and contaminants are separated as solutes in the mobile phase 
according to their interaction with the stationary phase (the matrix). If 
they have no affinity to the matrix, i.e. remain partitioned in the solvent 
of the sample, then they will pass straight through the column with no 
retardation. If they have a high affinity for the matrix they may totally 
adsorb onto it, and be impossible to remove without causing damage to 
the solute. These two scenarios are of little practicable use, except if the 
solute in question is an impurity in which case the first situation may be
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desirable. There are two further possibilities; firstly the situation where 
the substance has an affinity for the matrix so mild that it is simply 
slowed down in its passage down the column, thus delaying its elution 
long enough for totally non-binding impurities to be washed off. In the 
cases of the fields being studied here however, the situation of interest is 
that where the solute binds to the matrix such that it is effectively 
stationary while the solvent used for loading is flowing through, but 
where conditions can be easily modified to elute the target solute when 
so desired.
Chromatography is widely used as a late or final stage in the purification 
of fine chemicals or biological products since as a process step it can 
achieve very high degrees of purity of final product. In addition 
chromatography does not place the substances involved under any high 
shear forces or create problems with heat generation or dissipation and as 
such can be considered a gentle process step.
The types of chromatography utilised in this thesis are IEX and HIC. A 
brief description of these is provided below.
1.4.1 Ion Exchange Chromatography
Ion exchange chromatography (IEX) is based on the interaction between 
charged solute molecules and oppositely charged moieties covalently 
linked to a chromatography matrix.
IEX is a very common form of chromatography for the separation and 
purification of proteins and other charged biomolecules as it is a very 
simple, powerful and controllable method (Ion Exchange 
Chromatography Principles and Methods). Separation is achieved by the 
difference in interaction between the various substances in the sample 
and the ion exchanger, which can be controlled by conditions such as 
ionic strength and pH. Differences in interaction arise from differences in 
charge, charge densities and charge distribution.
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The ion exchanger is equilibrated to a state in terms of pH and ionic 
strength that promotes binding of the desired solute molecule. Upon 
sample application, the solute molecules displace the counter ions 
(usually simple ions such as chloride or sodium) from the equilibration 
buffer and bind reversibly to the matrix. The solute molecules can then be 
removed from the column usually by a change in ionic strength or pH.
In general, an increase in the conductivity of the sample leads to a 
reduction in binding of the solute molecule. As such, fermentation broths 
that typically have high conductivity levels that are loaded onto IEX EBA 
steps, require dilution in order to reduce the conductivity. However 
novel ion exchangers such as STREAMLINE Direct CST (see later for 
details) are able to operate effectively at high conductivity levels and 
offer similar performance as compared with the more typically utilised 
ion exchange matrices such as DEAE and SP.
1.4.2 Hydrophobic Interaction Chromatography
Hydrophobic interaction chromatography (HIC) utilises the fact that the 
surfaces of globular proteins have extensive hydrophobic patches in 
addition to the expected hydrophilic groups. These hydrophobic regions 
bind to the hydrophobic ligands, alkyl or aryl side chains on the gel 
matrix, under conditions favouring interaction e.g. aqueous solutions 
with high salt concentrations.
A large number of theories have been proposed to explain hydrophobic 
interaction chromatography. Most of the theories are essentially based 
upon the interaction of hydrophobic solutes and water (Tanfor, 1973; 
Creighton, 1984). None of the theories have enjoyed universal acceptance 
but common to them all is the central role of structure-forming salts and 
the influence they exert on the solute, solvent and adsorbent within the 
chromatography system.
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The type and concentration of salt are two factors of great importance in 
hydrophobic interaction chromatography, as are additives that change 
the polarity of the solvent. The influence of salt on hydrophobic 
interaction follows the well knows Hofmeister (lyotropic) series shown in 
Figure 1.1 (Pahlman et a l, 1977). Salts that promote hydrophobic 
interaction are to the left in the series. Hydrophobic interactions are 
increased in the presence of salts such as ammonium sulphate to a greater 
extent than salts lower down the Hofmeister series.
Anions: P043' > S042' > Cl' > Br' > N03' > CL04' > I' > SCN'
Cations: NH4+ > Rb+ > K+ > Na+ > Cs+ > Li+ > Mg2+ > Ca2+ > Ba2+
Figure 1.1: The Hofmeister Series on the effect of some anions and cations on 
promoting hydrophobic interactions.
Other factors to consider are the ligand and base matrix type and 
operating pH. The effect of pH is complicated. In general an increase in 
pH was found to decrease hydrophobic interaction (Porath et a l, 1973) 
probably as a result of the titration of charged groups leading to the 
increased hydrophilicity of the proteins. Other reports suggest that 
hydrophobic interaction increases as pH decreases (Halperin et a l, 1981).
Studies have shown that more than one ligand on the adsorbent m ust be 
involved in the binding of proteins to hydrophobic supports (Hjerten et 
al, 1974). Hydrophobic interaction chromatography is, in general, a mild 
method due certainly to the stabilising influence of salts and the 
recoveries are often high (Scopes 1994).
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1.5 Expanded Bed Adsorption
Expanded bed adsorption is a single pass operation in which products 
(usually proteins) are recovered from a crude feedstock. In this respect 
the operation seeks to combine the specificity of separation and overall 
volume reduction of chromatography with the clarification efficiency of a 
centrifugation and filtration system into one discrete step. This would be 
hoped to reduce the need for costly and time-consuming prior 
clarification steps such as centrifugation and filtration.
Expanded bed adsorption is suitable for the recovery of both extracellular 
and intracellular products; the former by direct capture from a fermenter 
or cell culture broth and the latter after homogenisation or cell lysis. As 
an effective operation it "came of age" in 1993 with the introduction of 
the STREAMLINE process range of expanded beds and matrices 
produced by Amersham Biosciences, Uppsala, Sweden and the FastLine 
range from UpFront Chromatography A/S, Copenhagen, Denmark.
The problem to which expanded bed operation became a solution was the 
requirement to combine three key aspects of the capture stage of a 
process -  clarification, concentration and product stabilisation. Although 
filtration and centrifugation systems can achieve the first two objectives 
to varying degrees, some form of more specific separation is required to 
remove such things as proteases. If these are not removed then the 
product could be at risk and time constraints are enforced between the 
capture and later purification steps.
Initial attempts to combine both crude separation techniques and some 
form of chromatographic separation were hampered by the approaches 
adopted. Overly complex methods relied on keeping the adsorbent 
particles stationary at all times - in effect a packed bed but with greater 
voidage. In order to achieve this, a good deal of work (Chetty and Burns 
1991; Terranova and Burns 1991) was carried out considering stabilising 
ferromagnetic adsorbent beads in an external magnetic field. This method
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has had a good deal of success with virtually no mixing or movement of 
the particles and thus plug flow is achievable. However the drawbacks 
are great - the need for expensive and heavy-duty magnetic equipment 
coupled with the problem of heat generation, especially in systems which 
require the temperature to be kept low to prevent biodegradation.
Draeger and Chase (1991) looked at the possibility of using conventional 
packed bed matrices expanded in a column. Although they found that 
the matrix could be expanded to 2-3 times its settled height, this was 
achieved at very low flowrates thus limiting the possible applications to 
systems requiring very low throughput. In addition this can cause serious 
problems because the uniform density of the matrix beads causes 
inherent instability in the bed, resulting in turbulent flow and the 
accompanying eddies, backflow and dead spaces.
Since plug flow through a packed bed maximises the num ber of 
theoretical plates in the system (NTP), then an expanded bed exhibiting 
turbulent flow will have an inferior adsorption performance to an 
equivalent packed bed exhibiting plug flow. This greatly increases the 
amount of time needed to perform the separation and also the am ount of 
debris retained by the column, often resulting in fouling of the matrix or 
the column. Although Chase (1994) has shown that when a bed is 
expanded where the solid-liquid density difference is minimal there is 
visually little mixing and the bed retains a uniform character during 
expansion, stability and complete plug flow would be unlikely. In 
addition a minimal density difference between the two phases precludes 
the use of high flowrates, or feedstocks of high viscosity, as the bed 
expands proportionally more under these situations.
Draeger and Chase (1991) also considered the adsorption characteristics 
of both Q-Sepharose (strong anion exchanger) for BSA solutions and 
Protein A Sepharose CL-4B (affinity) for hum an immunoglobulin G. They 
noted that when solutions of pure protein were used the breakthrough
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characteristics were similar to that of the matrix in packed bed mode, 
however w hen cells or cell debris was introduced into the sample the 
adsorption performance greatly deteriorated. In addition the increase in 
viscosity of the sample caused over-expansion of the bed due to minimal 
density difference between the solid and liquid phases.
Consequently, in order for the true potential of expanded bed adsorption 
as a downstream processing operation to be realised, a method was 
needed to stabilise the bed under adsorption and ensure that the flow 
through the bed remained as close as possible to plug flow. Several 
m ethods have been suggested to aid this. The inclusion of baffles around 
the side of the column (Buijs and Wesselingh, 1980) is said to stabilise the 
bed when used in conjunction with standard packed bed matrices, but 
this does not solve the problem of small density differences between the 
solid and liquid phases, and so flowrates used were still minimal. The 
development of STREAMLINE adsorbents and columns designed 
specifically for EBA overcame these problems of stable fluidization and 
are described in 1.5.1.
1.5.1 STREAMLINE Expanded Bed Products
The work carried out by Draeger and Chase (1991) indicated the need for 
matrix particles with a higher sedimentation velocity (the full 
mathematical descriptions regarding fluidization are included in 
Appendix I). Their work also introduced the use of a purpose designed 
liquid distribution inlet providing plug flow in the column. In 1993 
Amersham Biosciences introduced new columns and adsorbents called 
STREAMLINE specifically for use in EBA. Overall, the use of these 
products provided a single processing step to clarify, concentrate and 
purify the product, thereby increasing yields. An added advantage of 
EBA is the lack of cell damage that has been noted in the literature 
(Lutkemeyer et al., 1999).
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1.5.1.1 STREAMLINE Adsorbents
Almost all matrices used nowadays for fixed bed chromatography are 
porous structures. Increased porosity leads to high efficiency on account 
of reduced pore diffusion resistance and also allows for easier elution and 
washing of the matrix particles (Gondkar et al. 2001). The matrix is 
usually composed of hydrophilic polymer and in addition to this, certain 
other properties are desirable in the matrix. As well as hydrophilicity, an 
absence of groups to which proteins can spontaneously bind is desirable. 
A degree of physical and chemical stability is also required to cope with 
certain processes such as sanitisation (often 1M or stronger NaOH) and 
regeneration and repacking of columns after loss of activity. Other 
properties depend specifically on the process under consideration. Final 
important considerations include ensuring that the matrix material is 
porous enough to allow proteins to penetrate to an internal network of 
pores, thus ensuring maximum surface area for adsorption w ith 
minimum volume of matrix.
The most simple and effective system to stabilise an expanded bed is that 
use by Amersham Biosciences in their STREAMLINE adsorbents. By 
grading the adsorbent beads with a distribution of size or density, the 
system is most effective - the density and size gradient means that upon 
expansion the bed is stable as individual beads adopt a stable height in 
the bed based upon their density (Willoughby et a l, 2000(a)), and the 
heavy degree of matrix mixing observed in previous attempts is all but 
eradicated. To achieve the necessary particle gradients the beads are 
quartz-cored, thus giving a higher average density to the matrix than 
would normally be observed with fixed bed chromatography media (see 
Table 1.1 below). This has the additional benefit of allowing the system to 
support either higher flowrates or higher feedstock viscosities, as an 
increase in either of these tends to cause the bed to expand further but an 
increase in density of the matrix would result in a drop in expanded 
height.
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Base Matrix Ligand Mean Density 
(kg/m 3)
Particle Size 
Distribution (pm)
Agarose-quartz DEAE 1.15 100-300
Agarose-quartz SP 1.15 100-300
Agarose-quartz IDA 1.15 100-300
Agarose-quartz Heparin 1.15 100-300
Agarose-metal Protein A 1.3 80-165
Table 1.1: Illustration of densities and particle sizes for various types of 
STREAMLINE expanded bed adsorption matrices (Amersham Biosciences, 1997)
The physical properties under expansion of both of the ion exchange 
matrices (DEAE and SP) listed above have been reviewed by Chang et al. 
(1993) when compared to equivalent Sepharose Fast Flow matrices. They 
found that, under conditions of equal bed expansion, the flowrate in the 
STREAMLINE matrix was considerably higher.
Amersham Biosciences have widened greatly the varieties of 
STREAMLINE adsorbents available in the last few years. Initially only 
low specificity ligands such as ion exchangers and HIC groups were 
produced, because of concerns relating to the more harsh cleaning and 
regeneration steps required for processes which handle crude feedstocks. 
Fiowever, these ligands do not possess the high specificity for the 
separation product which is often required nowadays for maximum 
purity. Thus several new adsorbents have been developed based on the 
STREAMLINE system.
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1.5.1.2 STREAMLINE Hardware
Experiments carried out for this thesis were conducted using 
STREAMLINE 25 and STREAMLINE 50 columns supplied by Amersham 
Biosciences. These are two of the smallest of the presently available 
expanded beds the company produce, and are intended for use in process 
development and method optimisation. The two columns have, 
respectively, 25 and 50 mm internal column diameters and are both 1 m 
in length.
The extra equipment required to run the STREAMLINE 25 and 50 
columns is very similar to that required for standard packed bed 
chromatography. The system requires pumps, valves, fraction collection 
and on line spectroscopy/pH  m easurem ent/conductivity measurement 
as required. Details of system specifics can be found in Chapter 2 of this 
thesis.
Note that the upper adaptor in this system is hydraulic and can be raised 
or lowered by means of a pum p feeding to a reservoir above the adapter. 
This allows for simple alteration of the adaptor height, which is 
important as bed height can vary considerably during a run and the bed 
is functioning most efficiently when the upper adapter is positioned as 
close as possible to the top of the bed to minimise dead space. In addition 
to this, the hydraulic adapter opens up the possibility of eluting bound 
particles in the reverse direction (i.e. downwards) and therefore eluting 
the bed in packed mode rather than expanded mode.
In order to ensure efficient separation, it is important that the column is 
completely vertical. Misalignment of the column, even to degrees that are 
not detectable by visual inspection, can increase the liquid dispersion, 
leading to reductions in the separation efficiency (Bruce et al., 1999(b)).
An expanded bed that exhibits stable behaviour under fluid flow 
conditions (such as a STREAMLINE system) can allow certain 
conclusions to be draw n concerning the hydrodynamic behaviour of the
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bed under expansion. DeLuca et al. (1994) considered the effect of the 
design of the liquid distributor in terms of the effect on the bed expansion 
and on the hydrodynamic properties. They found that the value n in the 
Richardson-Zaki equation (Equation A I.ll in the appendix) depended on 
the design of the distributor, but also that the height of the bed upon 
expansion was reduced by having a lower settled bed height. This is not 
to be expected since the stable position (in terms of height) of any particle 
in an expanded bed depends on the density and size of the particle and 
the linear velocity of the fluid in the column but not on its starting height.
This led researchers to look more closely at the particle behaviour and 
draw  the conclusion that the design of distributors was often causing 
channelling of liquid, especially in beds with low initial height, causing 
uneven expansion. They also stated that, to ensure channelling did not 
effect the stability of the bed, the distributor should be of a design such 
that fluid flow is even over the entire cross-section of the bed, and also 
that the height of the settled bed should be at minimum double the value 
of the diameter of the column. In general also it was noted that bed 
stability upon expansion increases with settled bed height, but in 
addition, as settled bed height is increased, constraints are placed on the 
maximum liquid linear velocity in the column and also the use of high 
viscosity solutions, both for reasons of excessive bed expansion.
In order to overcome these issues, STREAMLINE expanded beds are 
fitted with special flow adapters underneath the bottom mesh net of the 
column. These ensure the flow of liquid into the column is distributed 
evenly across the entire cross-section of the column. In addition the holes 
in the adapter and the mesh are large enough to allow the passage of 
particulate matter, even whole cells, but are small enough to confine the 
matrix within the column in settled or downward elution mode.
Custom built columns have been developed that allow the removal of 
liquid or particle samples from within the expanded bed. It has been
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shown that in-bed sampling does not affect the separation efficiency and 
is a useful tool for investigating hydrodynamic and adsorption behaviour 
within the expanded bed (Bruce et al., 1999(a), Bruce and Chase 1999, 
2001 and 2002, Chase et al., 1999, Willoughby et al., 2000(a) and 2000(b)).
1.5.2 Operation
A typical chromatography process consists of six steps -  matrix 
preparation, equilibration, loading (adsorption), washing, elution and 
column regeneration. These steps are similar in almost all forms of 
chromatography, but with variations depending on specific processes. A 
general description of these processes is given below, but more specific 
details depend on the exact process.
This section is not intended to replace the materials and methods sections 
in Chapter 2 but rather to provide the reader w ith an introduction to the 
general context of the operation.
1.5.2.1 Matrix Preparation
In the initial stages the bed m ust be prepared and fully expanded. The 
bed is intended to be run at a settled bed height of approximately 15cm 
(Amersham Biosciences recommendations). The bed m ust then be slowly 
expanded up to a linear flowrate of approximately 400 cm / hr. This 
allows all the particles to rearrange to their proper position in relation to 
their size/density and ensures that, once settled again the bed will be 
stable in future expansions. In addition it is often necessary, especially 
with prototype adsorbents, to elutriate the material during expansion to 
remove any excessive fine particles that may be present and that will 
prevent a sharp boundary on expansion between the bed and the liquid.
1.5.2.2 Bed Expansion and Equilibration
Initially the bed is expanded in an upw ards direction using the 
equilibration buffer. According to Chang and Chase (1996) and 
Amersham Biosciences recommendations the bed should be expanded to
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approximately 2-3 times the settled height. Hjorth (1997) suggests that for 
most adsorbents and buffers w ith viscosities in the order of that of water, 
this expansion can be achieved with a linear liquid flowrate of 300cm/hr.
1.5.2.3 Adsorption of Sample
When the bed is fully expanded and equilibrated at the required liquid 
flowrate and has stabilised, the liquid being passed through the column is 
switched to the load sample. The length of load period will depend on 
the specific conditions required. In some cases samples may be loaded 
until a specific percentage breakthrough of target substance is achieved, 
in other cases simply a fixed volume may be loaded.
For efficient adsorption the physiological conditions (pH, ionic strength) 
of the sample and the column m ust allow effective binding. Ideally the 
conditions should be optimal for the interaction between the substrate 
and the ligand. This can be achieved by various methods varying from 
simple pH alteration through desalting and chemical additions to 
complex modifications such as dialysis and buffer exchange. Although 
other primary recovery operations may well be necessary in order to 
clarify samples destined for fixed bed chrom atography it is hoped that 
these will not be necessary when the sample is introduced to an 
expanded bed, w ith the possible exception of initial treatments to release 
intracellular products.
There is some degree of disagreement about methods of loading. Since 
the load samples are often of high viscosity relative to the buffers used 
then the bed expansion in the load step will be higher than in any other 
step. Consequently the liquid flowrate may need to be altered. Chang and 
Chase (1996) advocate keeping the bed height and therefore degree of 
expansion constant at all times by varying the liquid flowrates and show 
higher productivity can be achieved using these methods. On the other 
hand, Bamfield-Frej et al. (1994) suggest that the liquid flowrate should be 
kept constant allowing the bed expansion to vary according to the
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viscosity of the liquid being loaded. This has the advantage that the bed 
height does not need to be m onitored constantly, which is difficult when 
loading opaque liquids such as yeast homogenate or where other than 
borosilicate glass columns are used, although techniques to monitor bed 
height based upon ultrasonic waves (Thelen and Ramirez, 1999) or LED 
based sensors (Ghose et al., 2000) have been suggested as possible 
solutions to this. In this thesis, all EBA experiments have been carried out 
at constant loading velocity in order to mimic scaled-up industrial 
processing conditions.
1.5.2.4 Washing
When the load step is complete the column is washed. This step is carried 
out to remove any traces of cell debris and non-binding substances such 
as contaminating proteins or weakly bound contaminants from the 
column.
In general washing is carried out using equilibration buffer for simplicity 
and ease of preparation. Draeger and Chase (1991) studied the effect of 
highly viscous wash buffers on volumes of liquid required and effects on 
elution and found that, while the addition of glycerol to wash buffers to 
increase viscosity reduced the wash volume required it also appeared to 
have a detrimental effect on elution. Equilibration buffer is run through 
the column until all waste material is removed from the system.
1.5.2.5 Elution
After washing, the required products and any remaining contaminants 
are removed from the column. This step is known as elution. In the event 
of other contaminants being still present on the column then the elution is 
carried out in such a way as to ensure the product is contaminant free (i.e. 
multiple step elutions). The m ethod of elution varies depending on the 
method of chromatography but buffer changes, pH changes and salt 
gradients are common methods.
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Elution from an expanded bed is frequently carried out with the bed in a 
packed configuration, i.e. the bed is allowed to settle after washing and 
the upper adapter lowered to the top of the settled bed. Elution is then 
most commonly carried out in a dow nw ard direction at a lower flowrate 
to minimise the elution peak w idth although either direction is possible 
(Hjorth, 1999, Lihme et a l, 1999). Elution can be carried out using a step 
or gradient protocol as w ith packed chromatography, although scale 
requirements mean that step elutions are favoured.
1.5.2.6 Regeneration
After elution the column m ust be cleaned. Clean-in-place (CIP) 
procedures for STREAMLINE matrices given in literature vary according 
to the type of matrix, usually due to the varying chemical stabilities of the 
different matrix functional groups. Most are based around a caustic wash, 
although strengths of NaOH solutions used tend to vary in the order of 
0.1-1M NaOH. In addition some workers advocate an alternating 
acid/alkali wash (usually acetic acid) for enhanced cleaning, and storage 
is invariably in 20% ethanol. Specific matrices such as rProtein A are 
cleaned using agents such as 6M GuHCl since the immobilised protein A 
would be damaged by the action of NaOH.
If the column is to be immediately reused then it is usually regenerated 
by washing with equilibration buffer specific to the type of 
chromatography being carried out. Otherwise cleaning buffers are 
washed out of the system with water and the column stored in 20% 
ethanol or sodium azide solution to prevent bacterial growth.
1.6 Recent Developments -  STREAMLINE Direct 
Expanded Bed Products
The next generation of STREAMLINE products, named STREAMLINE 
Direct are now available commercially and address the problems that 
were commonly encountered w ith the original STREAMLINE products.
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1.6.1 STREAMLINE Direct Adsorbents
The work in this thesis provided the opportunity to work with prototype 
second generation STREAMLINE AIEX matrices (see Chapters 6 and 7). 
Whilst these are not available commercially, STREAMLINE Direct CST, a 
multi modal cation version is (Data File STREAMLINE Direct CST I), that 
is based on the same base matrix.
The density of the matrix beads has been increased from 1.15 to 1.8 g /m L  
as compared w ith the traditional STREAMLINE matrices. This allows 
higher operating velocities in the region of 600-900cm/hr thereby 
reducing processing time.
The adsorbent beads are smaller w ith a mean particle size of 135pm 
(compared to 200pm for STREAMLINE DEAE and SP). Smaller adsorbent 
particles are advantageous as they lead to an increased breakthrough 
capacity (Karau et a l, 1997).
In addition to this the ligand can w ithstand high ionic strength thus 
minimising the feed dilution required to reduce the conductivity, as is 
typically the case w ith IEX. Operation at these high conductivity levels 
has the additional benefit of preventing undesirable cell/adsorbent 
interactions that have been problematic and can lead to eventual bed 
collapse in IEX separations (Feuser et a l, 1999).
Combined, these developments reduce the processing time and buffer 
consumption, thereby increasing the overall processing economy.
This matrix is compatible w ith the existing STREAMLINE hardw are and 
is also designed to operate in the new STREAMLINE Direct columns, 
described below.
1.6.2 STREAMLINE Direct Hardware
The new STREAMLINE Direct columns have been designed to overcome 
the problems of streaming, blocking and trapped air bubbles that are 
commonly encountered w ith the already available EBA columns. The
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design is based on an oscillating distributor at the base of the column that 
removes the need for a bottom  adaptor mesh (Data File STREAMLINE 
Direct 24 and 95 columns). Similar types of distribution systems have 
been positively reviewed in the literature (Zafirakos and Lihme, 1999). 
Due to this, all operations are carried out in an upw ards flow, including 
the elution step. The new column is designed to work specifically with 
the new STREAMLINE Direct range of matrices.
1.7 Conclusions
This chapter has presented the theory and development of expanded 
beds and has also outlined the theory behind general chromatographic 
separations. This is all aimed at providing the reader with a basic 
understanding of this unit operation.
The next chapter outlines the materials and methods employed for all the 
experimental work carried out in this thesis.
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2 M a t e r ia l s  a n d  M e t h o d s
All chemical reagents used were laboratory grade obtained from Sigma 
Aldrich Fluka (Poole, Dorset, UK) and Amersham Biosciences (Uppsala, 
Sweden). Pre-made bacterial culture reagents were obtained from Oxoid 
(Hampshire, UK). All experiments were carried out in triplicate to ensure 
reproducibility.
2.1 Bacterial Cell Growth
Fermentation protocols were developed for E. coli DH5a containing the 
ampicillin resistant plasmid pGEX-5X-l (gift from Howard Chase, 
Cambridge University, Cambridge, UK), expressing GST under the 
control of the tac promoter, inducible with isopropyl P-D- 
thiogalactopyranoside (IPTG).
2.1.1 Cell Culture Media
2.1.1.1 Nutrient Broth No.2
Prepared according to manufacturers (Oxoid) guidelines by the addition 
of deionised H 2O. This was then sterilised by autoclave (121 °C, 20min) 
and supplemented with 0.1 g /L  ampicillin via a 0.2pm sterile syringe 
filter (Whatman, Brentford, UK). This procedure was applied to both 
Nutrient Agar and Nutrient Broth.
2.1.1.2 Terrific Broth
Prepared according to manufacturers (Oxoid) guidelines by the addition 
of deionised H2O and 10% w /v  glycerol. This was then sterilised by 
autoclave (121 °C, 20min) and supplemented with 0.1 g /L  ampicillin via a 
0.2pm sterile syringe filter (Whatman).
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2.1.1.3 High Cell Density Media
Prepared according to Korz (Korz et al., 1995) supplemented with lO g/L  
of Yeast Extract (Oxoid). The base media, carbon source, trace elements, 
yeast extract and Fe Citrate media components were made up separately 
in solution to prevent precipitation and sterilised by autoclave (121 °C, 
20min). The thiamine and ampicillin were prepared as stocks and added 
via a 0.2pm sterile syringe filter (Whatman).
Base M edia
KH2PO4 
(NH4)2HP04 
Citric Acid
C arbon  Source
Glycerol 
M gS04
Trace E lem ents
EDTA 
C0 CI2 
MnCh 
CuCl2 
H3BO3 
Na2Mo04 
Zn(CH3COO)2
O ther A dditions
Yeast Extract lO.Og/L
Thiamine 4.5g/L
Fe Citrate lO.Og/L
Ampicillin 0.1 g /L
13.3g/L
4-0g/L
1.7g/L
30.0g/L
1.2g/L
8.4 x 10-3g /L
2.5 x 10-3g /L
15.0 x 10-3g /L
1.5 x 10-3g /L
3.0 x 10'3g /L
2.5 x 10-3g /L
13.0 x 10-3g /L
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2.1.2 Glycerol stock preparation and maintenance
Nutrient agar plates were prepared as described in 2.1.1.1 with ampicillin 
added to select for cells harbouring the plasmid. Cells were applied to 
plates in a standard three way streak, and incubated at 37°C overnight.
Colonies were transferred aseptically to 50mL shake flasks containing 
lOmL nutrient broth prepared as per 2.1.1.1. The cultures were grown 
overnight until approximately 1 hour prior to stationary phase in an 
orbital shaker (New Brunswick Scientific, Hatfield, UK) at 37°C and an 
agitation rate of 200rpm. The culture was then suspended in sterile 
glycerol (50% w /v ) and aliquoted into 2mL stocks. These master stocks 
were frozen at -70°C to be used for re-culturing fresh working stocks, by 
repeating the above procedure. The working stocks were frozen at -20°C 
to be used for cell culture and were given a two month life span after 
which time they were replaced.
2.1.3 Shake Flask Fermentation
2L shake flasks were prepared with 250mL of selected media, prepared as 
described in 2.1.1. These were inoculated aseptically using a working 
glycerol stock prepared as described in 2.1.2 that was thawed at room 
temperature. Cells were then grown in an orbital shaker at 30°C and 
200rpm (New Brunswick Scientific). For growth and expression 
investigations, cells were grown until stationary phase and where 
appropriate, glutathione S-transferase (GST) expression was induced 
with the aseptic addition of Im M  IPTG; for inoculum preparation, cells 
were harvested approximately one hour prior to stationary phase.
2.1.4 5L Fermentation
Fermentations of E. coli DH5a expressing GST were performed in 7L 
bioreactors with a 5L working volume supplied by LH Fermentation 
(Adaptive Biosystems, Luton, UK) with the offgas stream connected to a 
mass spectrometer (MM8-80S, VG Gas Analysis Ltd., Windsworth, UK).
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Dissolved oxygen tension (DOT) and pH probes were calibrated and 
positioned within the fermenter along with the antifoam probe. The 
vessel was then filled with the desired volume of base media (allowing 
for any additions and inoculum) as the cells were grown in the High Cell 
Density media described in 2.1.1.3, which was then sterilised in-situ 
(121°C, 20min). To prevent precipitation, other media components were 
autoclaved separately where appropriate and added aseptically; media 
components that were not autoclaved were injected aseptically using a 
0.2pm sterile syringe filter (Whatman).
Once all the media components had been added, the operating conditions 
were set and these were then controlled via feedback control. The pH  was 
set to 6.7 and was then controlled by automated addition of acid (1M 
H2SO4) and base (4M NaOH). Foaming was monitored via the antifoam 
probe and was controlled by the automated addition of polypropylene 
glycol (PPG). Temperature was set and controlled at 30°C. Air flow was 
set and controlled at 5L /m in and agitation rate was initially set and 
controlled at 500rpm. The DOT was maintained at a minimum of 40% 
using cascade control by increasing the agitation rate.
Two 2L shake flasks described in 2.1.3 were prepared using the High Cell 
Density media and were used to inoculate the fermenter. Throughout the 
fermentation, samples were taken at regular intervals to measure for 
optical density (OD6oonm) and GST activity. Cells were grown until an 
OD6oonm of approximately 20 was reached at which point GST 
expression was induced by the addition of ImM  IPTG via a 0.2pm sterile 
syringe filter. Cells were grown for a further three hours and then 
drained for downstream processing.
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2.2 Downstream Processing
2.2.1 Cell Disruption
2.2.1.1 Sonication
Samples to a maximum of 5mL were chilled on ice and cells lysed by 
sonication for lm in  with lOsecs on/off pulse (Soniprep 150, Sanyo 
Scientific, Bensenville, IL).
For larger volumes to a maximum of 250mL, samples were chilled on ice 
and lysed by sonication for 10 mins with 9.9secs on /off pulse at 80% 
amplitude (Sonics Vibracell 750 Watt Model using 13mm probe, 
Newtown, CT).
2.2.1.2 Homogenisation
Volumes to a maximum of 5L were disrupted in a high pressure 
homogeniser (Lab 60, APV Ltd., Crawley, UK) fitted with a restricted 
orifice discharge valve for five discrete passes at 500bar with the 
temperature maintained at 5°C.
2.2.2 Clarification
Two types of centrifuge were used in this research; a bench microfuge for 
small scale clarification and a lab scale centrifuge for larger scale 
clarification.
2.2.2.1 Bench top centrifugation
A microfuge (Sanyo Scientific) was used to harvest cells or remove 
insoluble material. Cells were harvested for 5min and 13,000rpm.
2.2.2.2 Lab scale centrifugation
Clarification of larger volumes of material was carried out in a Beckman 
J2 centrifuge (Beckman Coulter, Fullerton, CA) fitted with a Ja-10 rotor at 
10,000rpm for 30mins with cooling.
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2.3 Biological Systems
This section describes the various biological systems used in this study 
and includes details of their preparation for use in both expanded and 
packed bed chromatography, along with details of the chromatography 
buffer/m atrix/Clean-in-place (CIP) systems employed.
2.3.1 Alcohol Dehydrogenase/Yeast
2.3.1.1 Feedstock Preparation
Bakers' yeast in the form of pressed blocks (DCL Ltd., Clackmannanshire, 
UK) was used as a source of the intracellular protein Alcohol 
dehydrogenase (ADH). Yeast was made into a 250g/L (wet weight) 
suspension in 0.1M potassium phosphate buffer. This was then disrupted 
in a high pressure homogeniser as per section 2.2.1.2. The homogenised 
feed was then either clarified as per 2.2.2.2 for packed bed studies, or left 
unclarified for expanded bed runs. In each case, the feed was then 
assayed for ADH activity as described in 2.6.6 and diluted to 100 U /m L  
ADH activity (±20%). In the process, the feed was also made up to 0.78M 
ammonium sulphate for optim um  binding to the matrix (Smith et al, 
2002).
2.3.1.2 Chromatography Details
ADH was captured via hydrophobic interaction chromatography (HIC) 
using STREAMLINE Phenyl matrix. Separations were carried out in both 
packed beds with 20mL matrix equivalent to a 10cm bed height and 
expanded beds in the STREAMLINE 50 column described in 2.4.1 
containing 200mL matrix, also equivalent to a 10cm settled bed height. 
Equilibration buffer used was 0.78M (NH ^SCh + 0.1M KH2PO4 and 
elution buffer was 0.1 M KH2PO4. All chromatography runs were carried 
out with buffers and feed materials maintained at 4°C.
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In order that each bed was challenged with the same quantity of ADH 
and to maintain the same product to matrix ratio, a feed of 1L volume 
was used for all expanded bed experiments and lOOmL for packed bed 
experiments such that the matrices were challenged with 500Units ADH 
per mL matrix. In all cases, pooled samples of feed, load, wash and 
elution were collected in order to mass balance the process and determine 
the amount of product bound to the bed.
2.3.1.3 Clean-in-Place Procedure
The CIP procedure was carried out using 10 column volumes 1M NaOH 
followed by 120 minutes NaOH contact time, 3 column volumes 25% v /v  
acetic acid, 3 column volumes 30% v /v  isopropyl alcohol and 5 column 
volumes 20% v /v  ethanol. Each of these stages were interspaced w ith 3 
column volume water washes.
2.3.1.4 Residence Time Determination
Residence Time Distribution (RTD) curves were obtained by recording 
the UV trace resulting from a step change from water + 0.5g/L blue 
Dextran 2000 to water and calculated as described below in 2.6.7 The 
choice of Blue Dextran 2000 as a marker is discussed in Chapter 4.
2.3.2 Glutathione S-Transferase/E. coli
2.3.2.1 Feedstock Preparation
E. coli expressing GST was grown in High Cell Density media either in 
shake flasks or 7L fermenter vessel (5L working volume) as per the 
methods of 2.1.3 and 2.1.4 respectively, dependent on the scale required. 
The broth was frozen in batches at -20°C until it was required at which 
point it was thawed at 4°C overnight. The feedstock preparation then 
followed one of the following routes dependant on its use:
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Clarify, D isrup t and  Clarify
The thawed broth was clarified as per 2.2.2 and the cell pellet was 
resuspended in 0.02M Tris/H Cl pH 8.5 either with or w ithout 0.2M NaCl 
added to adjust the conductivity. This was then disrupted as per 2.2.1 
and the soluble protein was isolated via centrifugation as per 2.2.2.
Clarify and  D isrup t
The thawed broth was clarified as per 2.2.2 and the cell pellet was 
resuspended in 0.02M Tris/H Cl pH 8.5 containing 0.2M NaCl. This was 
then disrupted as per 2.2.1 and diluted as appropriate with 0.02M 
Tris/HCl pH 8.5.
D isrup t
The thawed broth was disrupted as per 2.2.1 and diluted to reduce the 
conductivity to lOmS/cm. In the process the feed was also made up to 
0.02M Tris/H Cl pH 8.5.
23.2.2 Chromatography Details
GST was captured via anion exchange chromatography (AIEX) using the 
following matrices (full details of the prototype ligands can be found in 
Chapter 6):
■ STREAMLINE DEAE
■ STREAMLINE base matrix coupled to DAB (prototype ligand)
■ Prototype high density base matrix couple to DEAE
■ Prototype high density base matrix coupled to 3 prototype high 
salt tolerant ligands.
Separations were carried out in both packed beds using lOmL matrix 
(equivalent to a 5cm bed height) and expanded beds in the 
STREAMLINE 25 column described in 2.4.2 containing between 75 - 
lOOmL matrix equivalent to a 15 - 20cm settled bed height (total column 
height is lm).
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Equilibration buffer used was 0.02M Tris/H Cl pH 8.5 and elution buffer 
was 50mM Potassium Phosphate containing 1M NaCl pH 6.0.
In all cases, pooled samples of feed, load, wash and elution were 
collected in order to mass balance the process and determine the am ount 
of product bound to the bed.
2.3.2.3 Clean-in-Place Procedure
The CIP procedure was carried out as described in 2.3.1.3.
2.3.2.4 Residence Time Determination
Residence Time Distribution (RTD) curves were obtained by recording 
the UV trace resulting from a step change from water + 0.25% (v/v) 
acetone to water and calculated as described below in 2.6.7. The choice of 
acetone as a marker is discussed in Chapter 5.
2.3.3 Bovine Serum Albumin/Buffer
2.3.3.1 Feedstock Preparation
A 5m g/ mL solution of Bovine Serum Albumin (BSA) was made up in 
50mM Tris/HCl pH 7.5 buffer either with or without 0.25M NaCl added 
to adjust the conductivity.
2.3.3.2 Chromatography Details
BSA was captured via AIEX chromatography using the three prototype 
ligands coupled to the prototype high density base matrix detailed in 
Chapter 6. Equilibration buffer used was 50mM Tris/HCl pH 7.5 and 
elution buffer was 50mM Tris/H Cl pH 7.5 containing 1M NaCl.
2.3.3.3 Clean-in-Place Procedure
The CIP procedure was carried out as described in 2.3.1.3.
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2.4 Expanded Bed Chromatography
2.4.1 STREAMLINE 50
2.4.1.1 System Details
The STREAMLINE 50 column used for expanded bed separations was a 
modified, ported STREAMLINE 50 expanded bed described by 
Willoughby et al, 2000(b). The glass column (total length of lm ) was 
equipped with side ports every 5cm up the axis of the column. A total of 
10 ports were made to cover the full expanded height of the bed (~50cm). 
These ports were plugged w ith rubber bungs when not needed. Selected 
sample ports, depending on the amount of matrix in the column were 
fitted with custom-made sampling tubes with mesh sinters to prevent 
matrix removal during liquid sampling. Peristaltic pum ps (model 505DI, 
Watson-Marlow Ltd., Cornwall, UK) were used for buffer and feed 
application and to raise and lower the column hydraulic adaptor. All 
valves and equipment were from the Amersham Biosciences range. The 
automated CIP cycle was controlled via an LCC 500 Plus controller and a 
P-6000 pum p (Amersham Biosciences). The output from the column was 
monitored for UV-absorbance at 280nm and conductivity using 
Amersham Biosciences monitors, and these values logged using a PE 
Nelson 900 interface and Turbochrom v4 (both Perkin Elmer Nelson 
Systems Inc., Boston, MA).
Samples were taken from the ported column, using a Gilson Minipuls 
multiroller peristaltic pum p (Gilson, Villiers le Bel, France) at a flowrate 
of 2mL/ min. This flowrate was selected to provide an adequate supply of 
fresh material for analysis w ithout disturbing the bed stability 
(Willoughby et al, 2000(a)).
Samples were passed to the custom built stopped-flow analyser (SFA) 
described in more detail in 2.6.6 which operated on a split stream from
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the 2m L/m in sample line and enabled the removal of a small sample of 
liquid (approximately lmL) for analysis every 55 seconds.
2.4.1.2 Mode of Operation
Expansion and equilibration were carried out at the running flowrate 
until the bed was fully equilibrated at which point feed was loaded onto 
the column in an upw ards direction and at the same flowrate. On-line 
samples were taken at an axial height equivalent to the top of the matrix 
while the bed was expanded. Adaptor height was maintained 
approximately 5cm above the top of the bed. After loading, the bed was 
then switched back to equilibration buffer and the column washed 
upw ards at the same flowrate until the UV 280nm trace had returned to 
baseline. As in the load step, on-line samples were taken at an axial 
height equivalent to the top of the matrix while the bed was expanded for 
the rem ainder of the wash. Flow was then halted and the bed allowed to 
settle. The hydraulic adaptor was then lowered to a height level with the 
top of the settled bed. The direction of flow was reversed and the product 
eluted in a downward direction at 75cm /hr until the product peak had 
been completely eluted. This took 20mins and was collected in two 
sample pools of equal volume. The CIP procedure was carried out at 
90cm /hr immediately after elution in an upwards direction.
2.4.1.3 Matrix Elutriation and Segregation
In order to segregate STREAMLINE matrix into sections containing 
different particle size ranges, the STREAMLINE 50 column was filled 
with 300mL matrix and was elutriated in expanded mode to form three 
sections of equal settled matrix volume (lOOmL). By doing this, the 
individual sections corresponded to different particle size ranges since 
the top third of the expanded bed contains the smallest particles, and the 
bottom third the largest particles.
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This procedure was repeated with a number of batches so as to prepare 
similar sections that were combined to generate "segregated" beds of the 
desired volume.
2.4.2 STREAMLINE 25
2.4.2.1 System Details
The STREAMLINE 25 expanded bed column (total column length is lm ) 
was connected to an AKTA Explorer 100 modified by the use of an AKTA 
STREAMLINE kit and controlled by Unicorn 4.1. The output from the 
column was monitored for UV-absorbance at 280nm and conductivity 
and these values logged via the Unicom software. Fractions were 
collected where appropriate with a Frac-950 (all Amersham Biosciences).
2.4.2.2 Mode of Operation
Expansion and equilibration were carried out at the running flowrate 
until the bed was fully equilibrated at which point feed was loaded onto 
the column in an upwards direction and at the same flowrate. The 
adaptor was maintained approximately 5cm above the top of the bed. 
After loading, the bed was then switched back to equilibration buffer and 
the column washed upw ards at the same flowrate until the UV 280nm 
trace had returned to baseline. Elution was then either carried out at the 
same running flowrate in an upw ards direction, or flow was halted and 
the bed allowed to settle. In the latter case the hydraulic adaptor was then 
lowered to a height level with the top of the settled bed. The direction of 
flow was reversed and the product eluted in a downw ard direction at 
75cm /hr until the product peak had been completely eluted. The CIP 
procedure was carried out at 90cm /hr immediately after elution in an 
upwards direction.
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2.5 Packed Bed Chromatography
All packed bed separations were carried out in XK16 columns containing 
the desired quantity of expanded bed matrix that had been packed by 
employing a fluid downflow in excess of the running flowrate, and 
according to guidelines from Amersham Biosciences. Separations and 
CIP procedures were controlled by an AKTA Explorer 100 running 
Unicom version 4.1 in a downwards direction with fractions being 
collected throughout the load, wash and elution where appropriate with 
a Frac-950 (all Amersham Biosciences).
2.6 Monitoring and Analysis
2.6.1 Optical Density
Optical density was determined using sample absorbance at 600nm, as 
measured against a blank of the media being used for cell culture. A 
Uvikon 922 UV/VIS spectrophotometer (Kontron Instruments S.p.A, 
Milan, Italy) was used. Samples were diluted as necessary with ultra pure 
water in order to adjust the absorbance below one unit at a wavelength of 
600nm (the limit of linearity of the spectrophotometer).
2.6.2 Dry Cell Weight
To determine the dry cell weight within the cell cultures, lm L samples 
from the fermentation were placed into Eppendorf tubes that had been 
dried at 105°C for 24 hours and pre-weighed. Cells were then recovered 
by centrifugation as per 2.2.2.1, supernatant was discarded, and the 
sample was dried at 105°C for 24 hours and weighed. Dry cell weight was 
then determined by subtraction of the original Eppendorf weight.
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2.6.3 GST Assay
The detection of GST was based on the change in absorbance at 340nm as 
GST catalyses the reaction between l-chloro-2,4-dintrobenzene (CDNB) 
and glutathione resulting in a CDNB-glutathione product with a strong 
molar absorption at 340nm. GST activity was determined following the 
method described in the GST detection module (Amersham Biosciences). 
In this assay a sample of GST is incubated in a reaction buffer containing 
lOOmM CDNB and 30.8mg/mL glutathione for 5 minutes and the initial 
rate is used to determine GST concentration.
Assays were performed at room  temperature in 1cm path length cuvettes 
with lm L assay mix in a UVIKON 922 UV/VIS spectrometer. The 
reaction was started by the addition of the enzyme. Sample volumes were 
adjusted and where necessary were diluted with potassium dihydrogen 
phosphate buffer (lOOmM, pH 6.5) to produce a linear change in 
absorbance between 0.1-0.8 AU. Assays were reproducible to ±5%.
Results were expressed in terms of units of enzyme activity where one 
unit (U) is defined as the am ount of GST required to react lp m o l/m in  of 
glutathione with CDNB. Activity was converted to units using the molar 
extinction coefficient of the CDNB-glutathione product at 340nm, 
e=9.6/ m M /cm . An activity of 9.96U/mg GST was assumed (Kaplan et al. 
1997).
2.6.4 Total Protein (Bradford) Assay
The Bradford assay was used to determine total protein levels (Bradford, 
1976). The assay is based on the shift in absorbance from 465nm to 595nm 
which occurs when Coomassie blue G-250 dye binds to proteins in acidic 
solution. A commercially available dye was used (Bio-Rad, Hemel 
Hempstead, UK). Bovine Serum Albumin was used to construct a 
calibration curve with a range of 0.1-1.Omg/mL. Protein concentration 
was then obtained from the calibration curve.
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2.6.5 SDS-P AGE Gels
Samples from cell cultures were investigated by SDS-P AGE. 
Electrophoresis was carried out using the discontinuous buffer system 
and method of Laemmli (Laemmli, 1970).
2.6.5.1 Protein Preparation
Cells were harvested by centrifugation as per 2.2.2.I. Pellets were 
resuspended and boiled in appropriate amounts of sample buffer (40mM 
Tris/HCl pH 6.8, 20% (v/v) glycerol, 2% (w /v) Sodium dodecyl sulphate 
(SDS), 5% (v/v) p-mercaptoethanol and trace bromophenol blue). 50pL of 
protein was loaded.
2.6.5.2 Gel Preparation, Running and Staining
12% monomer resolving gels were prepared using ProtoGel (National 
Diagnostics, Hull, UK). The gel solution contained 40% ProtoGel, 26% 
ProtoGel Buffer, and 34% ultra pure H 2O. Following pouring, gels were 
cast with the addition of lm L  10% (w /v) ammonium persulphate (freshly 
prepared), and IOOjiL TEMED to result in lOOmL of resolving gel 
solution. Gels were run at 200V for 35min in MES electrode buffer 
(Invitrogen).
Gels were stained using 0.1% (w /v) Coomassie brilliant blue R-250 in 
50% (v/v) methanol, and 10% (v/v) acetic acid for 2 hours on a rocker. 
Gels were destained using fast destain (40% (v/v) methanol, 10% (v/v) 
acetic acid) for 2 hours, followed by slow destain (10% (v/v) methanol, 
10% (v / v) acetic acid) for 4 hours.
2.6.6 ADH Assay
ADH monitoring was based on the initial rate of absorbance change at 
340nm as ADH catalyses the reduction of NAD+. Alcohol dehydrogenase 
(ADH) activity was determined following the method of Bergmeyer 
(Bergmeyer, 1979). All assays were performed in 1cm path length
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cuvettes and the reaction was started by the addition of the enzyme 
sample. Potassium dihydrogen phosphate buffer (lOOmM, pH 6.5) was 
used to dilute samples to produce a linear change in absorbance less than 
0.5 AU/m in.
The assay was carried out using a custom built stopped-flow analyser 
(SFA) connected to a computer-controlled spectrophotometer (Amersham 
Biosciences) equipped with controllable twin cuvettes (with 1mm and 
10mm pathlengths respectively). ADH concentration was determined 
using an initial rate assay carried out for 15 seconds after which the 
flowcells were automatically washed and the next sample analysis began. 
The total system time was 55 seconds and assays were carried out to a 
duplicate accuracy of ±5%.
Dilution of the samples was achieved in the SFA delivery system prior to 
analysis. The more concentrated samples were diluted one in 236 and the 
more dilute one in 17. Further dilution for the product (ADH) rate assays 
could be achieved by using different cuvette path lengths.
The results were logged by PC and plotted on screen to allow on-line 
operator monitoring of the system. All instruments were linked to a 
computer through serial RS232 and A /D  connections to facilitate data 
logging and instrument control. The software used for these purposes 
was based on Lab VIEW (National Instruments, Austin, TX). Full details 
of the SFA method can be found in other publications (Habib et al, 1997; 
Richardson et al, 1996).
2.6.7 Residence Time Determination
System residence times (tRsystem)  were determined for both packed and 
expanded beds. In both systems, residence time distribution (RTD) curves 
were obtained by recording the UV trace resulting from a step change 
from tracer molecule to water at the desired flowrate using the packed 
and expanded bed systems described above. RTD tests were carried out
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in triplicate to yield the num ber of theoretical plates (NTP), reproducible 
to within ±20%.
2.6.7.1 Packed Bed Operation
Once the residence time for the system (tRsystem) had been m easured, it 
was necessary to correct for the time delay due to tubing prior to and 
after the column (tRtubing) by measuring tubing length, cm (Ltubmg) and 
internal diameter, cm (ID tubing), such that:
2.6.7.2 Expanded Bed Operation
The true residence time in expanded beds was determined in a similar 
fashion to that of the packed beds. During the RTD tests the adapter was 
maintained at a height equivalent to the top of the expanded matrix, and 
a UV monitor was placed in the outlet stream of the bed. Once the 
residence time for the system (tR system ) had been measured, it was 
necessary to correct for the time delay due to tubing prior to and after the 
column and also for the difference in residence time attributed to the 
change in the degree of expansion achieved with the biological system 
applied to the column, as compared with water (tRheight).
The difference in bed height, AH (cm) due to expansion in the more 
viscous biological fluid was accounted for by measuring the difference in 
expanded height when the system was run with water as compared with 
the biological system. Given that the matrix mass and volume are 
constant, the change in system volume is solely due to an increase in bed 
voidage. Such a change will increase the system residence time. The
Q
(2 .1)
where Q is the volumetric flowrate, m L/ min through the tubing.
The true residence time for the bed was then:
t R p a c k e d  =  t R s y s t e m -  t R t u b i n g (2.2)
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internal diameter, cm (IDcolumn) of the column was known and hence 
using the flowrate at which the experiment was run (Q, m L/m in), it was 
possible to calculate the residence time for the extra height, tRheight (sec) 
by:
AH  x n x f IDcolum/y /  j 
tRheight = -------------—-------------x 60 (2.3)
The true residence time for the segregated bed (h>) was then calculated by 
subtracting from the measured residence time (t R s y s t e m ) the residence 
time due to the tubing (t R t u b i n g ) and subsequently adding on the 
residence time due to the extra height ( t R h e i g h t ) ,  therefore:
tR =  t R s y s t e m -  tR tu b in g +  tR h e ig h t  (2.4)
2.6.8 Matrix Particle sizing
Particle size ranges for each of the various matrix samples were 
determined using a Malvern Mastersize 2000 laser sizer (Malvern 
Instruments, Worcestershire, UK). This device employs a Low Angle 
Laser Light Scattering (LALLS) method to measure particles in the range 
0.1 to 2000 microns. Samples were added to a recirculating cell w ithin the 
sizer.
The values noted were the number diameter statistics dio, dso and d 9o. 
These are defined as the point on the particle distribution where, 
respectively, 10%, 50% and 90% of the particles are smaller than the 
stated diameter. The dio statistic is an indicator of the proportion of fines 
in a particle size distribution, whilst dso gives the mean particle diameter 
and d90 a measure of the proportion of large particles present. These 
statistics were selected in order to characterise the sample particle 
distributions.
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2.6.9 Number of Matrix Particles
RTD curves were recorded as described above in 2.6.7 in XK16 columns 
containing a known settled matrix volume (V t) using 0.5g/L Blue 
Dextran as a marker. V t can be defined as the total volume of matrix, 
consisting of matrix particles (Vm) and liquid (V i) such that:
Vt = V m + V l (2.5)
Once the true residence time, tRpacked described in 2.6.7.1 had been 
determined, and given the volumetric flowrate, Q m L/ min, through the 
column it was possible to calculate the volume of liquid in the sample of 
matrix from:
V l = Q x tRpacked (2.6)
Rearranging equation 2.5 allows the volume of matrix in a sample to be 
calculated as:
Vm = V t - V l (2.7)
The number of particles (Np) in a lm L sample can then be defined as:
=  T 1 rr (2.8)
4!3n(d5„:2)
Where dso is the mean diameter of a particle described in 2.6.8.
2.6.10Total Binding Capacity Measurements
Total binding capacities were determined for various matrices using a 
finite bath method, whereby sample containing product prepared 
according to the guidelines outlined above was assayed for product and 
diluted to the required concentration ([Product]o) and applied in excess to 
0.5mL samples of matrix in sealable tubes. These were then sealed and 
placed on a shaking rack and left for 5 hours. The supernatant was then 
assayed for product until a constant value was achieved ([Product]eqm). 
The difference in [Product]o -  [Product]eqm was taken as the total binding 
capacity of the matrix for product at the given product concentration.
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Various product concentrations of the same sample were used to prepare 
adsorption isotherms for segregated beds of STREAMLINE DEAE and 
the prototype high density base matrix coupled to the prototype high salt 
tolerant ligand DAB.
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3 T h e P r o d u c t io n  a n d  A n a ly s is  o f  G ST  
fr o m  E. COLI
3.1 Introduction
The overall aims of this study are to investigate the effects of operating 
parameters on the productivity of an EBA unit. Chapter 4 will look at 
these using a Yeast/ Alcohol Dehydrogenase (ADH) system. In order to 
establish the generic nature of the findings it is necessary to see if these 
results are transferable across different systems. A second system based 
on the purification of glutathione S-transferase (GST), an untagged 
intracellular protein, from an unclarified E. coli homogenate will be used 
to provide this test. GST (26kDa) is part of a family of proteins that 
catalyse the conjugation of reduced glutathione with a variety of 
hydrophobic chemicals containing electrophilic centres (Habig et al., 
1974).
The use of EBA to purify ADH from yeast homogenate has been well 
characterised (Smith et al. 2002, Willoughby et al. 2000(b)) as has the 
purification of GST from E. coli homogenate (Clemmitt et al. 2002), 
however, little work has been published on the production of GST from 
E. coli. In this chapter E. coli DH5a containing the plasmid pGEX-5X-l 
(Amersham Biosciences) expressing GST inducible with isopropyl p-D- 
thiogalactopyranoside (IPTG), has been grown in a variety of 
fermentation media in order to determine E. coli growth and GST 
expression and assess the conditions necessary to maximise material from 
the minimum number of fermentations. Based on these results, a choice 
of media was made for scale-up and it was then possible to explore the 
disruption and storage conditions needed for GST release. Finally the 
GST assay, as described in chapter 2, was examined with respect to the 
effects of reaction time and sample dilution level in order to identify
60
Chapter 3: The Production and Analysis of GST from E. coli
appropriate conditions necessary for the monitoring of this system and to 
enable rapid throughput and analysis of GST.
3.2 Fermentation Development
3.2.1 Effect of culture media on E. coli growth
In the first instance it was necessary to investigate the effect of the culture 
media on the growth of E. coli DH5a. Shake flask cultures were grown 
according to the methods in section 2.1.3 using three different media:
a) Nutrient Broth (Oxoid)
b) Terrific Broth (Oxoid)
c) High Density Media (Korz et a l, 1995) supplemented with 
lOg/L of Yeast Extract (Oxoid)
In each case, E. coli was grown aerobically at 30°C and 200rpm in 2L 
shake flasks (250mL working volume) until cell death, supplem ented 
with O.lg/L ampicillin. During growth, two lm L samples were removed 
every hour for measurement of optical density according to the methods 
in section 2.6.1 and dry cell weight (DCW) according to section 2.6.2 until 
growth had ceased, at which point the fermentation was stopped. All 
fermentations were carried out in triplicate. The growth curves for each 
of the media are shown in Figure 3.1 and the relationship between optical 
density and dry cell weight are shown in Figure 3.2.
These growth curves in Figure 3.1 demonstrate that E. coli DH5a can be 
grown reproducibly in each of the 3 media. Terrific Broth produced a 
greater dry cell weight of lOmg/mL, approximately 2 fold higher than 
the high cell density media and 10 fold higher compared to nutrient 
broth.
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Figure 3.1: Growth of £. coli DH5a within 3 different media. Cultures were grown in 
2L shake flasks with a 250mL working volume at 200rpm and 30°C.
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Figure 3.2: Relationship between optical density measurements (OD6oonm) and dry 
cell weight of £. coli DH5a grown in High Density Media.
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3.2.2 Effect of culture media on GST expression
Based on the growth curve results, the obvious choice would be to use 
Terrific Broth as this produced the highest dry cell weight of E. coli, 
however the aim here is to reproducibly produce high levels of GST and 
therefore it is important to investigate the GST expression in each of the 
three media. The shake flask fermentations were repeated and GST 
production was induced in each of the above media by the addition of 
IPTG to ImM. In each case, based on the growth curves obtained in 
Figure 3.1, IPTG was added 1 hour prior to the end of growth i.e. for 
Nutrient Broth, at an OD6oonm of 0.9-1.OAU, for Terrific Broth, at an 
OD6oonm of 15-16AU and for High Density Media, at an OD6oonm of 6- 
7AU.
The cultures were incubated for a further 3 hours. Samples were removed 
every hour post induction for analysis. Each sample was disrupted using 
an ultrasound sonicator for lm in  as per section 2.2.1.1 and levels of GST 
were determined using the GST detection module (Amersham 
Biosciences) described in 2.6.3. Results are shown in Table 3.1.
The final sample taken 3 hours post induction was also assayed for total 
protein using the Bradford assay (Bradford, 1976) as per 2.6.4 and was 
subsequently centrifuged as per 2.2.2.I. The supernatant was assayed for 
total protein and GST, and the remaining debris containing any trapped 
soluble product was resuspended in lOOmM Tris/H Cl pH 7.5 buffer and 
also assayed for total protein and GST. These results are shown in Table 
3.2.
SDS-P AGE gels were also run as per the methods in 2.6.5 for each media 
to carry out an analysis of the protein fractions (Figure 3.3 a, b and c for 
each media) in order to confirm assay results.
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Time from Induction 
(hours)
Nutrient
Broth
Terrific
Broth
High Density 
Media
0 0 0.375 0.042
1 0.029 0.398 0.055
2 0.075 0.656 0.157
3 0.121 1.444 0.266
Table 3.1: Levels of GST (mg/mL) detected in sonicated £. coli samples taken each 
hour post induction with ImM IPTG in three media grown in 2L shake flasks with a 
250mL working volume at 200rpm and 30°C.
Sample Nutrient
Broth
Terrific
Broth
High Density 
Media
Whole Broth sonicate 0.121 1.444 0.266
GS
T Supernatant 0.112 1.053 0.217
Resuspended Pellet 0.017 0.125 0.01
Whole Broth Sonicate 0.295 1.749 0.871
B
2
Supernatant 0.2175 1.402 0.85
Resuspended Pellet 0.16 0.5715 0.241
Table 3.2: Total protein and GST levels (mg/mL) detected in sonicated £. coli cell 
culture, resuspended pellet and supernatant taken 3 hours post induction with ImM 
IPTG.
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Figure 3.3: SDS-PAGE gels of proteins detected in £. coli samples taken each hour post 
induction in three media grown in 2L shake flasks with a 250mL working volume at 
200rpm and 30°C.
Figure 3.3a: Nutrient Broth
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Figure 3.3b: Terrific Broth 
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Assay analysis of GST levels in the three fermentation media showed that 
whilst Terrific Broth produced the highest final levels of GST it was also 
being produced prior to induction with IPTG, most likely due to the 
leaky effect of the promoter. Due to this difficulty in controlling the 
expression of the plasmid while growing on this media, Terrific Broth 
was disregarded as a choice for production of GST. Instead the High 
Density media was chosen as it had good growth coupled with high GST 
expression levels in soluble form.
The fermentation of E. coli DH5a was then scaled up to 7L (5L working 
volume) as described in section 2.1.4 using the High Cell Density media 
in order to produce GST for downstream processing. Figure 3.4 shows 
the growth curves in the 5L fermenter demonstrating that E .coli could be 
grown reproducibly to a final OD6oonm of 26 with an associated GST 
concentration of 0.7 m g/m L  (sample subject to lm in  sonication).
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Figure 3.4: Growth and expression of E. coli DH5a producing GST within a 5L 
fermenter using High Cell Density culture media.
This material and the developed protocol formed the basis for all EBA 
studies of GST that are reported in the remainder of this thesis.
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3.3 GST Assay Development
Once GST had been successfully produced it was possible to investigate 
the assay conditions necessary to achieve reproducible analysis of the 
EBA process step. According to the assay guidelines detailed in 2.6.3, the 
detection of GST is based on a rate assay at A340 where absorbance 
measurements are made every minute for 5 mins and should fall between 
0.1 and 0.8AU. In order to test these guidelines the effect of sample 
dilution and time of reaction on the assay results were investigated.
A sample of fermentation broth, three hours post induction was sonicated 
for 10 mins. The critical assay parameters were then tested by diluting the 
sample to different levels and assaying for GST, and also by measuring 
the absorbance over a 5 min period, with readings being taken every 10 
sec in the first minute to check that the rate was linear. The GST 
concentration was then determined for each sample based on 1 and 5 
mins reaction time. These results are shown in Figure 3.5.
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Figure 3.5: Effect of assay sample volume and reaction time on the measured 
concentration of GST produced in E. coli DH5CX. The highlighted points are those where 
the absorbance readings fell within the linear range of the spectrophotometer.
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It can be seen in Figure 3.5 that a decrease in sample dilution i.e. an 
increase in overall sample volume in the assay leads to an apparently 
decreasing GST concentration when running the assay on the same 
sample source. At both high and low dilution levels, the assay was 
difficult to reproduce to within ±5%. The most reproducible assay results 
were when the absorbance readings fell between 0.1-0.8AU as per the 
guidelines. This is identified in Figure 3.5 as occurring at a sample 
volume of 0.005mL for this particular sample under investigation. In this 
region of dilution, the differences in measured GST concentration upon 
reducing the reaction time from 5mins to lm in  was only 2%. These 
results provided the basis for a consistent GST assay used throughout the 
study to gain rapid data on the EBA process. The sensitivity of the assay 
to the sample preparation methods indicates the importance of 
establishing robust methods for each system under examination.
3.4 GST Release
During the course of the GST assay development it was noted that the 
GST concentration measured after sonicating for lOmins was more than 
double that compared with 1 min (1.5 m g/m L  c/0.7 m g/m L) implying 
that maximum GST release was not achieved when sonicating for lm in. 
This led to an investigation of GST release kinetics and of the effect of 
harvest/storage conditions on GST levels.
A sample of fresh fermentation broth 3 hours post induction was passed 
through a Lab 60 homogeniser for 5 passes at 500bar as described in 
2.2.1.2 ("fresh”). Samples were removed at each pass and assayed for GST 
concentration.
In order to investigate the impact of harvesting and storage conditions of 
the fermentation broth on subsequent GST release, a sample of fresh 
fermentation broth 3 hours post induction was frozen at -20°C and then 
thawed at room temperature and passed through the homogeniser. This 
material was termed ”frozen”. Another sample of fresh fermentation
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broth 3 hours post induction was clarified as per section 2.2.2 and the cell 
pellet and supernatant were frozen separately at -20°C, then thawed at 
room temperature and recombined and passed through the homogeniser. 
This material was termed "spun". GST concentration (m g/m L) at each 
pass for the above samples in shown in Figure 3.6.
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Figure 3.6: Comparison of 3 harvesting and storage conditions of E. coli DH5a (fresh 
broth, frozen broth and clarified/frozen broth) and their effect on GST release when 
passed through an homogeniser for 5 passes at 500bar.
As can be seen from Figure 3.6 each of the samples achieve the highest 
measured level of GST release after 5 passes though the homogeniser. It 
would appear that the fresh broth contains the most GST as compared 
with the frozen and spun broth. FJowever it was noted that the fresh 
broth was the first sample to be assayed. The sample was re-assayed after 
completing all the other samples. The new GST concentration was lower 
(see check point) and appears to have dropped relative to the initial 
measurement.
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The explanations for the results reported in sections 3.2 -  3.4 are 
discussed in the following section.
3.5 Discussion
Three culture media were evaluated for growth of E. coli and expression 
of GST. It was possible to reproducibly grow E. coli in each of the media. 
Nutrient broth produced the least E. coli and Terrific broth produced the 
most. However upon investigation of GST expression, it was found that 
in the case of Terrific broth GST was present at the point of induction 
with IPTG indicating that control of plasmid expression was difficult in 
Terrific broth. Due to this, Terrific broth was disregarded as a culture 
media and the High Cell Density media was chosen for further work as 
growth levels were high, coupled with good plasmid control and 
expression.
This media was then successfully and reproducibly scaled up to 5L 
working volume. The levels of E. coli increased 3 fold as compared to the 
shake flask (from a dry cell weight of 5m g/m L to 13mg/mL) as did the 
levels of GST (from 0.27mg/mL to 0.7mg/mL) when comparing using 
similar disruption strategies. This is to be expected as the oxygen transfer 
is vastly improved in a fermenter coupled with the ability to control pH.
Work was then carried out on the GST assay using the same sample 
source to investigate the effect of sample dilution and reaction time. It 
was found that over or under dilution of the sample led to inaccurately 
high or low GST concentrations respectively. To produce consistent 
results, it was necessary to dilute the sample such that the Amorim 
absorbance readings fell between 0.1-0.8AU, as per the assay guidelines. 
Once this criteria was met it was possible to consider the effect of reaction 
time on the assay output.
The assay guidelines suggest a reaction time of 5mins, however 
decreasing this reaction time to lm in  leads to a difference in GST
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concentration of only -2%. Considering that the assay is accurate to 
within ±5%, it was decided that the reaction time could be safely reduced 
to 1 min for all future work provided the AMonm absorbance readings fell 
between 0.1-0.8AU.
Despite assays having been carried out as per the assay guidelines it was 
observed that samples from the 5L working volume fermenter that had 
been sonicated for lm in  had GST levels of 0.7mg/mL compared with 
samples that had been sonicated for lOmins that had GST levels of 
1.5mg/mL. This would indicate that maximum GST release was not 
achieved in lm in  of sonication. To verify this, samples were disrupted in 
a high pressure homogeniser to investigate the GST release kinetics. 
Various harvest and storage conditions were also investigated at this 
point to determine their impact on cell strength and consequently their 
effect on GST release.
Results demonstrated that the highest measured GST release is achieved 
after 5 passes at 500bar for all harvest and storage conditions 
investigated. It would appear on initial inspection that the broth which 
was homogenised immediately after fermentation released the most GST, 
however this sample was re-assayed once all other assays were complete. 
It was found at this point that the level of GST in this sample had 
dropped from 2.2mg/mL to 1.5mg/mL, putting it in line with the other 
samples. Fresh assay mix was used in the first sample and hour old assay 
mix was used for the check result. This implies that the assay mix 
degrades over time, most likely due to the reaction of glutathione with 
CDNB in the absence of GST that forms a chemical moiety that absorbs at 
340nm. All subsequent measurements in this thesis were based upon 
fresh assay mix.
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3.6 Conclusions
Conclusions that may be draw n from this work are that E. coli can be 
reproducibly grown to a dry cell weight of 13m g/m L and GST produced 
to a concentration of 1.5mg/mL in a 5L working volume fermentation 
employing High Cell Density media.
The highest measured GST release is achieved by lOmins sonication or 5 
passes at 500bar in a homogeniser. Harvest and storage conditions do not 
have an impact on the apparent cell strength and hence GST release 
indicating that frozen cell paste can be used as the basis for downstream  
processing studies. This is a key result as it enables a break point to be 
established between culture and subsequent processing studies.
GST can be reproducibly detected to within ±5% using the GST assay and 
a reaction time of 1 min providing the assay mix is fresh and absorbance 
readings at 340nm fall within 0.1-0.8AU.
The work carried out in this chapter provides the basis for an analysis of 
the effect of expanded bed adsorption operating parameters and matrix 
properties on the purification of GST from E. coli (detailed in Chapter 5) 
as compared to those when investigating the purification of alcohol 
dehydrogenase from Yeast homogenate, in Chapter 4. This GST/E. coli 
system will also be employed when studying prototype expanded bed 
matrices, in Chapters 6 and 7.
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D istr ibu tio n  a n d  O pera tin g  V elocity o n  
the  Pu r ific atio n  of A lcohol  
D eh ydro g enase  fro m  Yeast
4.1 Introduction
In the study of expanded beds, little consideration has been given to the 
impact of having matrix particles of different sizes present within an 
expanded bed adsorption (EBA) column during product breakthrough. 
Previously Willoughby et al., 2000(a), 2000(b), Bruce and Chase, 2002, 
2001,1999 and Chase et a l, 1999 studied various aspects of expanded bed 
behaviour and in particular used in-bed sampling and on-line monitoring 
to consider the breakthrough of products and contaminants along the 
axis of the bed. Of particular interest was the observation (Willoughby et 
al, 2000(b)) that the largest particles (those that remained in the bottom 
third of the bed during expansion) were seen to provide over 60% of the 
binding capacity of the column in a typical 10% product breakthrough 
loading strategy.
Karau et a l, 1997 demonstrated with a single component system that 
small matrix particles had an enlarged breakthrough capacity as 
compared with large particles and it was speculated that smaller particles 
may lead to mass transfer limitations upon expansion due to the 
increased bed voidage, especially when applying viscous feedstocks such 
as yeast homogenates.
Breakthrough curves at the column outlet of expanded beds are typically 
much shallower than those observed in traditional packed bed 
chromatography (Smith et a l, 2002) and a possible explanation for this is 
that the utilisation of the matrix is a function of particle size distribution
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(PSD). By contrast in a packed bed there is no significant particle size 
gradient along the axis and hence the bed capacity is constant in the axial 
direction.
The variation in binding potential along the expanded bed axis implies 
that a better bed productivity might be gained via an improved 
understanding of these effects. This and the next chapter set out to gain 
such knowledge of the effects of matrix PSD utilising the smallest and 
largest particles available from within a typical EBA matrix and operating 
flowrate on the breakthrough behaviour observed in an EBA column. 
This chapter will consider the purification of alcohol dehydrogenase 
(ADH) from Yeast homogenate via hydrophobic interaction 
chromatography (HIC) and the productivity implications of the results 
will be discussed in Chapter 8.
4.2 Matrix Segregation and Characterisation
STREAMLINE Phenyl matrix was elutriated as described in 2.4.1.3 and 
the particle size ranges of these samples were measured as described in
2.6.8 to confirm that the elutriation successfully separated the original 
bed into three segregated beds (termed "smallest", "medium" and 
"largest") each internally consistent in terms of size but with dissimilar 
particle size distributions (PSD's). A graph of decumulative PSD is shown 
in Figure 4.1. Table 4.1 contains the num ber diameter statistics d io ,  d so  
and d 9o defined in 2.6.8 demonstrating the variation in particle size 
distributions for the different segregated beds.
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Figure 4.1: Decumulative particle size distribution measurements on a number basis 
for different sections of segregated STREAMLINE Phenyl matrix.
dio, pm dso, pm dgo, pm
Smallest 114 150 204
Medium 119 156 214
Largest 136 181 251
Table 4.1: Particle size range variations as shown by dio, dso and d% measurements on 
a number basis for different sections of segregated STREAMLINE Phenyl matrix.
The segregated beds were further characterised by calculation of the 
number of particles in lm L of matrix for each of the beds, based on the 
methods in 2.6.9. The total binding capacity (based on the methods in 
2.6.10) of ADH in g /L  when applying yeast homogenate prepared as 
described in 2.3.1.1 was also determined. These results are summarised in
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Table 4.2 for the largest and smallest particles only, as these provided the 
widest extremes of particle size.
Total Binding Capacity 
(grams of ADH per L matrix)
Number of particles (Np) 
per mL of settled matrix
Largest 1.94 209,837
Smallest 3.89 336,005
Table 4.2: Characterisation of segregated STREAMLINE Phenyl detailing the total 
binding capacity for ADH when applied at a concentration of lOOU/mL and the number 
of matrix particles per mL of settled matrix.
4.3 Velocity and Particle Size Effects on 
Breakthrough
Purification of ADH from Yeast homogenate prepared as described in 
2.3.1.1 was carried out according to the methods in 2.4.1.2 for expanded 
bed chromatography and 2.5 for packed bed chromatography, using the 
buffer system described in 2.3.1.2. The STREAMLINE Phenyl segregated 
beds consisting of the smallest and largest particles were used in order to 
enable the effect of particle size to be determined. These sections were 
chosen as they contained the widest extremes of particle size. 200mL of 
matrix was used in the STREAMLINE 50 column described in 2.4.1.1 as 
this corresponded to a settled bed height of 10cm, the minimum height 
recommended for this column to achieve stable expansion (Hjorth et al., 
1995); 20mL of matrix was used in the XK16 columns, equivalent to 10cm 
bed height.
In order to investigate the effect of load velocity on the recovery and 
breakthrough characteristics of ADH, experiments were carried out on 
these segregated beds at flowrates of 100 and 300 cm / hr in both packed 
and expanded modes of operation.
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The breakthrough curves for the expanded and packed bed runs are 
shown plotted in Figures 4.2 and 4.3, with Figure 4.2 demonstrating the 
effect of flowrate on a segregated bed of the largest particles in both a 
packed (4.2a) and an expanded bed (4.2b) and Figure 4.3 demonstrating 
the effect of particle size at various velocities in both packed (4.3a) and 
expanded beds (4.3b and c). As the velocity was varied, Figure 4.2 is 
plotted on a volume loaded basis for ease of comparison. Figure 4.3 is 
plotted against time.
Figure 4.2: The effect of linear liquid velocity (100 and 300 cm/hr) on the 
breakthrough of ADH loaded onto a segregated bed of STREAMLINE Phenyl consisting 
of the largest matrix particles in a) packed and b) expanded beds.
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Figure 4.2a: Largest particles in a packed bed compared at 100 and 300 cm/hr.
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F igu re 4.2b: Largest particles in an expanded bed compared at 100 and 300 cm/hr.
F igu re 4.3: The effect of particle size on the breakthrough of ADH loaded onto packed 
and expanded beds at constant linear liquid velocity.
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F igu re 4.3a: Smallest and Largest particles in a packed bed compared at 300cm/hr.
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Figure 4.3b: Smallest and Largest particles in an expanded bed at lOOcm/hr.
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Figure 4.3c: Smallest and Largest particles in an expanded bed at 300cm/hr.
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4.4 Impact of Residence Time on Breakthrough 
Profiles
For each expanded bed set-up (i.e. small and large particles; 100cm/hr 
and 300cm/hr) RTD tests were carried out as described in 2.6.72 using 
0.5g/L Blue Dextran as tracer molecule. The results are summarised in 
Table 4.3, giving details of the residence times due to tubing and that due 
to the extra degree of expansion while processing the homogenate. The 
number of theoretical plates (NTP) values are also presented. The results 
were also used to calculate t/tR  where t is the experimental time (secs) and 
tR is calculated as described in 2.6.72. This was used in the breakthrough 
curves analysis at varying fluid velocities and PSD, shown in Figure 4.4.
Residence 
Time (sec)
Large Particles Small Particles
lOOcm/hr 300cm/hr lOOcm/hr 300cm/hr
tRsystem 579 282 663 338
tRtubing 202 68 202 68
tRheight 108 120 198 144
tR 485 334 659 414
NTP 19.8 13.7 26.1 15.8
Table 4.3 : Variation in residence time (sec) with bed arrangement.
4.5 Discussion
The objective of this work was to consider the effects on expanded bed 
performance of changes in the size distribution of matrix particles and the 
loading velocity. Elutriation of the original bed yielded 2 beds for study 
each containing quite different PSD's. The size difference between the 
elutriated particle samples is illustrated in Figure 4.1 and quantified in
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Table 4.1. On a number basis the mean size of the smallest particles was 
150pm compared to 181pm for the largest particles.
Table 4.2 summarises the main characteristics of the segregated beds. The 
total binding capacity was found to be almost double for the smaller 
particles compared with the larger particles, suggesting that the binding 
with ADH is predominantly external bead surface area binding (or the 
spherical surface area of the bead), as the smaller particles have a higher 
specific surface area than the large particles. The number of particles per 
mL of settled bed matrix was found to be higher for the smaller particles 
than the larger particles as would be expected, as a small particle, based 
on their average diameter of 150pm, would individually take up less 
space than a large particle of 181pm.
The number of theoretical plates was measured in each expanded bed at 
the three different linear velocities used for breakthrough and as 
expected, the number of plates decreased with both increasing particle 
size and increasing linear liquid velocity. This can be seen in Table 4.3. 
These results show that at the higher velocities the reduction in num ber 
of theoretical plates relates to a corresponding increase in axial dispersion 
in the bed. This might be expected to produce an earlier point of initial 
breakthrough coupled with a shallower profile for the higher velocities 
but, as can be seen in Figure 4.2, this effect does not seem to be 
significant. Differences in theoretical plate numbers between the largest 
and smallest particles at the same linear velocity are not large enough 
(<25% in all cases) to be significant when compared with the 
reproducibility of the measurement (±20%).
Figure 4.2 illustrates the effect of velocity on binding behaviour of a 
segregated matrix in both packed beds and expanded beds. As the 
velocity was varied for each experiment, the breakthrough curves are 
plotted against total volume loaded for ease of comparison. This is the 
conventional form of data presentation for both expanded and packed
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bed chromatography. From the breakthrough curves in the packed bed 
(Fig 4.2a), it is clear that increasing liquid velocity increases the rate of 
product breakthrough for particles of comparable size. This is to be 
expected and is a reflection of the mass transfer limitations experienced at 
higher velocities coupled with the reduction in contact time. Comparing 
this with Figure 4.2b in an expanded bed, whilst higher overall levels of 
breakthrough are achieved at a higher velocity, consistent w ith the 
packed bed data, the curves show that the breakthrough occurs earlier at 
the lower velocity. This is not the case in the packed bed. The difference 
in expanded bed behaviour is due to the extra degree of expansion that 
occurs at higher velocities in expanded beds.
Figure 4.3 illustrates the effect of particle size on breakthrough behaviour. 
Product breakthrough in the packed bed at 300 cm / hr is more rapid and 
reaches higher levels with the larger particles compared to smaller 
particles at the same velocity (shown in Fig 4.3a). This is to be expected as 
the higher specific surface area of the smaller particles leads to a higher 
capacity for product per unit volume of matrix. This is particularly true of 
ADH, a relatively large protein (~140 kDa) such that penetration of the 
matrix bead interior will be slowed by its size. Relatively limited 
penetration of matrix beads during loading has been illustrated using 
confocal microscopy of matrix beads (Linden et al., 1999) meaning that 
substantially only the matrix surface area is utilised for binding. This is 
confirmed by the total binding capacity experiments where it was found 
that the smaller particles had a total binding capacity double that of the 
large particles and would thus be expected to exhibit a later and 
shallower product breakthrough.
As the binding of ADH is mainly on the matrix surface the tracer 
molecule for the RTD tests was chosen to reflect this. Blue Dextran 2000 
has a very high molecular weight and thus does not penetrate the interior 
of the matrix particles, hence only passing through the voids between the
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particles (Willoughby et al., 2000(a)). This marker was therefore also used 
when determining the number of particles since it can be used to provide 
a measure of the excluded column volume i.e. the interstitial voidage.
If we compare Figure 4.3b to Figure 4.3a, effects noticed in the packed 
beds in 4.3a due to the particle size are also noticed in the expanded bed 
at low velocities (100 cm / hr), shown in Figure 4.3b. However, despite 
there being an obvious difference in the shape of the breakthrough curves 
between the small and large particles at low velocities, when running at 
higher velocities (300 cm /hr) breakthrough profiles are almost identical, 
with the small particles breakthrough shifted only slightly later in time 
than the larger particles (Figure 4.3c). This shift in time is due to the 
smaller particles expanding to a greater extent than the larger particles 
and thus, on a straight time or volumetric basis, the product 
breakthrough will be further retarded by the longer residence time of the 
bed.
The change in bed residence time as a function of matrix size and 
operating velocity makes direct comparison of product breakthrough 
characteristics in expanded beds of different diameter particles difficult. 
The standard approach of using time or volume to plot product 
breakthrough does not allow for the increase in residence time caused, 
for example, by the greater expansion of smaller particles relative to the 
larger size material. In order to compensate for this, a dimensionless 
residence time group was defined, t/tR, where t is the experimental time 
and tR is the residence time for the bed as defined by equation 2.4 in 
Chapter 2. This group takes into account differences in velocity and PSD 
as tR is a measurement of the time taken for liquid to pass through the 
column, itself dependent on velocity, but also on the degree of expansion 
and hence voidage, which are functions of the PSD.
Re-plotting the data in Figures 4.2b, 4.3b and 4.3c now using the 
dimensionless ratio t/tR as described earlier yields Figures 4.4 a - c
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respectively (the packed bed data was not replotted since the residence 
time was constant due to the small volume of matrix used; 120 secs at 100 
cm / hr and 39 secs at 300 cm /h r for the beds formed from both small and 
large particles). This figure demonstrates the difference in breakthrough 
curves obtained when running at different velocities and using different 
PSD's of matrix.
Analysing these new curves reveals that breakthrough curves remain 
similar in profile, but as expected the delay in breakthrough seen on a 
straight time or volume basis has been offset. The result is that 
breakthrough curves for the differently sized particles and at different 
liquid velocities can now be compared directly.
The effect of increasing velocity in limiting the mass transfer is still 
obvious when comparing similar segregated beds and in fact is easier to 
distinguish in an unambiguous fashion as the earlier breakthrough at the 
lower velocity seen in Figure 4.2b which is a product of the degree of 
expansion, has now been compensated for (Figure 4.4a).
The data also show that the effect of particle size is negated with 
increasing velocity in the expanded bed. At 100 cm /h r (Figure 4.4b) there 
is a noticeable delay in, and a lower overall rate of, breakthrough for the 
smaller particles when compared to the larger particles. This is consistent 
with the higher surface area of the smaller particles leading to a higher 
dynamic binding capacity.
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Figure 4.4: Comparison of breakthrough rates of ADH in expanded beds of 
segregated matrix at various linear liquid velocities plotted against dimensionless 
experimental time (t/tR).
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Figure 4.4a: Largest particles compared at 100 and 300 cm/hr.
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Figure 4.4b: Smallest and largest particles compared at 100 cm/hr.
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Figure 4.4c: Smallest and largest particles compared at 300 cm/hr.
We would expect this behaviour for the smaller particles to be 
maintained as the velocity is increased, as suggested by the packed bed 
results at 300 cm /h r (Figure 4.3a). However, this is not seen to be the 
case. At 300 cm /h r in the expanded bed (Figure 4.4c) there is no delay or 
difference in breakthrough for the smaller particles relative to the larger 
particles.
Taken together the results from these experiments would suggest that the 
binding at high velocities is limited by a factor other than surface area 
alone. Since the change in binding behaviour is more pronounced at 
higher velocities it seems likely that the effect of surface area is negated 
by the increased void volume achieved between small and large particles 
at high velocities (Willoughby et al., 2000(a)) leading to a reduced 
frequency of particle/ product collision and hence an observed fall off in 
the observed binding efficiency.
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4.6 Conclusions
The work described here illustrates the variation in the adsorptive 
behaviour of expanded beds formed from differently sized particles. The 
use of a dimensionless residence (t/tR) time allows for a direct comparison 
of breakthrough behaviour between such beds since it accounts for the 
changes in bed height due to variations in particle size and velocity. This 
approach has allowed us to demonstrate that, for the particular protein 
under study, the expected improved dynamic capacity of smaller beads is 
negated at velocities in excess of 100 cm /h r most probably by mass 
transfer limitations of the product binding to the matrix coupled with the 
effects of an increased void volume at higher velocities. With 
conventional time or volume based analysis such a conclusion would 
have been more difficult to infer.
Expanded beds are typically run at liquid velocities of up to 300 cm /hr. 
In the work presented here, use of t/tR analysis has enabled us to show 
that for the particular protein examined where the kinetics of binding are 
relatively slow, the EBA performance is not optimal under conditions of 
high liquid velocities that are used for EBA operation. This necessity to 
run at significantly lower velocities would tend to negate some of the 
advantages of EBA in terms of reducing early downstream processing 
times and minimising the risk of product degrading over time.
Continuation of this work in Chapter 5 examines the effect of matrix PSD 
and operating velocity on the purification of a product not limited by its 
size to adsorbance by surface area binding. The use of a dimensionless 
experimental time in this situation will be also be discussed. The 
productivity implications for both of these biological systems will be 
considered in Chapter 8.
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5.1 Introduction
In Chapter 4 it was stipulated that the productivity of an expanded bed 
column may be improved by careful selection of matrix particle size 
distribution. It was found for the system under investigation (ADH 
produced in Yeast and purified via HIC) where product binding was 
mainly limited to surface area binding, that at low velocities, the small 
matrix particles bound more product than the large matrix particles. 
However, when running at velocities in excess of 300cm/hr, this effect 
was negated due to mass transfer limitations. Due to the difficulty in 
comparing breakthrough behaviour in expanded beds at different 
velocities containing different matrices, the concept of a dimensionless 
experimental time was also introduced. This chapter seeks to extend this 
analysis to a different experimental system that is not limited by surface 
area binding.
The system under investigation will be the E. coli/GST  system developed 
in Chapter 3 whereby the GST is purified via anion exchange 
chromatography (AIEX). Studies will investigate whether differences are 
observed in breakthrough between the small and large particles at both 
low and high velocities and will consider the applicability and utility of 
the dimensionless residence time in the analysis of such a system.
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5.2 Matrix Segregation and Characterisation
STREAMLINE DEAE matrix was elutriated as described in 2.4.1.3 and 
the particle size ranges of the samples were measured as described in
2.6.8 to confirm that the elutriation successfully separated the original 
beds into three segregated beds each internally consistent but with 
dissimilar PSD's. The decumulative PSD graphs were extremely similar 
to those found with STREAMLINE Phenyl in Chapter 4 Figure 4.1 and so 
are not shown here. Instead, the number diameter statistics are 
summarised in Tabular form in Table 5.1 demonstrating the variation in 
particle size distributions for the different segregated beds of 
STREAMLINE DEAE.
dio, n^ri dso; l^ rn d90/ Mm
Smallest 120 145 208
Medium 116 158 213
Largest 137 178 249
T a b le  5.1: Particle size range variations as shown by dio, dso and d 9o measurements on 
a number basis for different sections of segregated STREAMLINE DEAE matrix.
As the PSD's were similar to that of the segregated STREAMLINE 
Phenyl, the number of particles was not recalculated. However in order 
to understand the kinetics of GST binding to STREAMLINE DEAE of 
varying PSD's, adsorption isotherms were produced for the smallest and 
largest particle size ranges. These were produced as described in 2.6.10 
by challenging samples of matrix with E. coli homogenate prepared as 
described in 2.3.2.1 containing varying concentrations of GST. The 
adsorption isotherms are shown in Figure 5.1.
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Figure 5.1: The adsorption isotherm for the binding of GST to segregated beds of 
STREAMLINE DEAE. C m is the concentration of GST (mg/mL) in the applied sample 
and Cs is the amount of GST (mg) bound to the matrix (mL).
As can be seen in Figure 5.1, there is very little difference in binding 
between the segregated beds consisting of the largest and smallest 
particles.
5.3 Velocity and Particle Size Effects on 
Breakthrough
Expanded bed purification of GST from E. coli homogenate prepared as 
described in 2.3.2.1 was carried out according to the methods in 2.4.2.2 
and the buffer system described in 2.3.2.2. This buffer system was based 
on the work carried out by Clemmitt and Chase (2002), however a step 
change in pH, used in conjunction with an increase in salt concentration 
and hence conductivity, was utilised in place of the salt gradients utilised 
by Clemmitt and Chase. This was in order to elute the maximum amount 
of GST and to mimic large industrial processes.
In each case, the STREAMLINE DEAE was challenged with lOOOmL 
disrupted E. coli containing 0.3mg/mL GST. The segregated beds
91
Chapter 5: The Purification of GST from E. coli
consisting of the smallest and largest particles were used in order to 
consider the effect of particle size. These sections were chosen as they 
contained the widest extremes of particle size. 50mL of matrix was used 
in the STREAMLINE 25 column described in 2.4.2.1 as this corresponded 
to a settled bed height of 10cm, the settled bed height utilised in the 
Yeast/ ADH system in Chapter 4.
In order to investigate the effect of load velocity on the recovery and 
breakthrough characteristics of GST, experiments were carried out on 
these segregated beds at velocities of 100 and 300 cm /hr.
The breakthrough curves for the expanded bed runs are shown plotted in 
Figures 5.2 and 5.3, w ith Figure 5.2 demonstrating the effect of velocity 
on a segregated bed of the largest particles (5.2a) and smallest particles 
(5.2b) and Figure 5.3 demonstrating the effect of particle size at 100 and 
300 cm /h r (5.3 a and b respectively).
Figure 5.2: The effect of linear liquid velocity (100 and 300 cm/hr) on the 
breakthrough of GST loaded onto a segregated bed of STREAMLINE DEAE consisting 
of the a) largest matrix particles and b) smallest matrix particles.
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Figure 5.2a: Largest particles in an expanded bed compared at 100 and 300 cm/hr.
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Figure 5.2b: Smallest particles in an expanded bed compared at 100 and 300 cm/hr.
Figure 5.3: The effect of particle size on the breakthrough of GST loaded onto 
expanded beds at constant linear liquid velocity.
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Figure 5.3a: Smallest and Largest particles in an expanded bed compared at 
lOOcm/hr.
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Figure 5.3b: Smallest and Largest particles in an expanded bed compared at 
300cm/hr.
5.4 Impact of Residence Time
For each expanded bed set-up (i.e. small and large particles; 100 cm /h r 
and 300cm/hr) the RTD tests were carried out as described in 2.6.72  
using 0.25% v /v  acetone as tracer molecule. The results are summarised 
in Table 5.2, giving details of the residence time due to tubing and that 
due to the extra degree of expansion while processing the homogenate.
Residence 
Time (sec)
Largest Particles Smallest Particles
lOOcm/hr 300cm/hr lOOcm/hr 300cm/hr
tRsystem 640 345 618 326
tRtubing 219 73 219 73
tRheight 162 72 216 132
583 344 615 385
Table 5.2: Variation in residence time (sec) with bed arrangement.
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The values obtained for tR were then used to calculate t/tR where t is the 
experimental time (secs) for the analysis of breakthrough curves at 
varying fluid velocities and PSD, shown in Figure 5.4.
5.5 Discussion
The objective of this chapter was to consider the effects on expanded bed 
performance of changes in the size distribution of matrix particles and the 
loading velocity using a system where adsorbance of the target molecule 
was not limited by its size to surface area binding as in Chapter 4. The 
matrix under study was elutriated into 2 beds for further study each 
containing different PSD's. The size difference between the elutriated 
particles is quantified in Table 5.1. As can be seen in this table, the 
number diameter statistics for the beds are very similar to those obtained 
in Chapter 4. This is to be expected as both of the adsorbents under study 
consisted of the same base matrix; the only difference between them  were 
the ligands to which they were coupled i.e. Phenyl and DEAE.
The adsorption isotherms for the segregated beds consisting of the 
smallest and largest particles can be seen in Figure 5.1. As this Figure 
clearly illustrates, there is very little difference in the binding potential 
between the smallest and the largest particles. In fact, the large particles 
have a slightly higher binding capacity than the small particles when 
challenged with higher concentrations of GST. This is most likely due to a 
larger volume of matrix available for binding within the large particles 
compared with the small particles. This confirms that GST is not limited 
by surface area binding, as was the case with ADH where the smallest 
particles bound almost double the quantity of ADH compared with the 
large particles. Due to the ability of GST to bind to the full volume of the 
matrix rather than just the surface, a penetrative tracer molecule was 
chosen to perform the residence time distribution tests. In this case, 
acetone was selected.
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Figure 5.2 illustrates the effect of velocity on binding behaviour of the 
segregated matrices. As the velocity was varied for each experiment, the 
breakthrough curves are plotted against total applied volume for ease of 
comparison. As can be seen, the behaviour follows similar patterns for 
both the small and large particles in that a higher overall breakthrough is 
achieved at the higher velocities due to mass transfer limitations and it 
occurs earlier at the lower velocities in both cases. This is consistent with 
the results obtained in Chapter 4, however the delay in breakthrough at 
the higher velocity is not as obvious as is the case for the results in 
Chapter 4. This is in part due to the larger intervals between data points 
obtained with the GST system.
Figure 5.3 illustrates the effect of particle size on breakthrough behaviour. 
Product breakthrough at the lower velocity is more rapid and reaches 
higher levels with the larger particles compared to the smaller particles at 
the same velocity (Figure 5.3a). However, despite there being a difference 
in behaviour at the low velocity, running at higher velocities (300cm/hr) 
leads to identical breakthrough profiles. There is no delay in 
breakthrough with small particles as observed with the yeast/A D H  
system in Chapter 4. This is discussed below.
If we now consider the impact of residence time on the observed 
breakthrough behaviours, and re-plot the data in Figures 5.3 (a & b) to 
yield Figures 5.4 (a & b) by application of the dimensionless time concept 
introduced in Chapter 4 (t/tR), it is clear that the breakthrough curves in 
Figures 5.4 (a & b) shown below do not differ greatly from those in 
Figures 5.3 (a & b).
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Figure 5.4: Comparison of breakthrough rate of GST in expanded beds of segregated 
matrix at various linear liquid velocity plotted against dimensionless experimental time.
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Figure 5.4a: Smallest and largest particles compared at lOOcm/hr.
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Figure 5.4b: Smallest and largest particles compared at 300cm/hr.
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This is due to the similarity in residence time at the same linear liquid 
velocity between the PSD's, quantified in Table 5.2 (583 and 615 secs at 
lOOcm/hr for the largest and smallest particles respectively and 344 and 
385 secs at 300cm/hr for the largest and smallest particles respectively). 
In addition the binding behaviour of GST is not limited to surface area 
binding, as was the case w ith ADH, but can utilise the full volume of the 
matrix. Hence the larger particles have a higher capacity available for 
binding. This is confirmed by the GST isotherms as the larger particles 
bound more GST than the small particles.
The higher capacity observed in the large particles is then effectively 
negated in an expanded bed by the extra degree of expansion obtained 
with the small particles. This leads to similar residence times for the small 
and large particles when comparing at the same linear liquid velocity. 
This similarity in residence time can then account for the lack of delay in 
breakthrough mentioned above.
If we now analyse the curves in Figure 5.4 similar conclusions can then 
still be drawn. At low velocities, the small particles perform slightly 
better than the large particles due to the slight increase in residence time 
that this system offers (30 secs more). However, at high velocities, whilst 
this difference in residence time still exists between the small and large 
particles, it offers no obvious advantage in terms of product binding. This 
is due to the binding at high velocities being affected by factors other 
than the residence time. As in Chapter 4, this is most likely due to the 
increased void volume observed between the small and large particles 
coupled with mass transfer limitations at this higher velocity.
Normalisation of breakthrough curves by t/tR for this system is not as 
obviously beneficial as when applied to the yeast/ADH system as the 
overall conclusions reached are the same without its application. 
However the use of residence time is still useful as it provides a deeper 
understanding of the differences observed in binding - for example the
98
Chapter 5: The Purification of GST from E. coli
difference in performance between the small and large particle at low 
velocities can be attributed to the increased residence time observed with 
the small particles upon expansion.
5.6 Conclusions
The work presented in this chapter illustrates that at low operating 
velocities small matrix particles offer an advantage in terms of product 
binding due to the increased residence time observed in these beds as 
compared to those consisting of only the large matrix particles. This is 
despite the large particles having a higher capacity for the product due to 
their larger volume available for binding.
When operating at higher liquid velocities, no advantage is offered when 
using the small matrix particles. This is due to the relatively large 
increase in the void volume in the small particle system coupled with 
mass transfer limitations. Given that expanded beds are generally run 
between 200-300cm/hr, no significant benefit would be offered through 
careful selection of the matrix particle size distribution in the case of GST 
which is a relatively small and hence mobile molecule.
The overall conclusions reached in this chapter are in agreement with 
those results in Chapter 4 even for products subject to different binding 
kinetics. Whilst it was possible to reach these conclusions without the use 
of a dimensionless time as introduced in Chapter 4, this is still a 
worthwhile measurement as it allows a deeper understanding of the 
results obtained.
The following chapters utilise the GST system from this chapter to 
investigate the effect of feed conductivity on expanded bed adsorption. 
Chapter 6 examines various prototype ligands for use in the conductivity 
studies, and Chapter 7 compares the performance of the selected 
prototype ligand with that of the more standard AIEX ligand, DEAE.
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Chapter 8 then considers the productivity implications of the work 
carried out in these chapters.
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6 Pr o t o t y p e  H ig h  S a l t  T o l e r a n t  A n i o n  
Ex c h a n g e  Lig a n d  Ev a l u a t io n
6.1 Introduction
Expanded beds have been successfully utilised to recover proteins 
directly from crude feedstocks. In many situations, affinity ligands are 
employed due to their specificity for the target molecule, however they 
can be a complex and expensive solution. Alternatives such as ion 
exchange provide less selectivity but offer cost advantages. Problems 
arise with these adsorbents due to their inability to perform well under 
conditions of high conductivity typical of many fermentation broths.
As expanded beds are used early on in downstream processing, feed 
volumes are already at their maximum. The need to dilute further these 
feeds to reduce ionic strength leads to high buffer consumption and long 
processing times.
In order to minimise the need to dilute, Amersham Biosciences have 
developed prototype ion exchange ligands that can operate at high ionic 
strengths. Three of these prototype anion exchange ligands will be 
considered in this chapter for their use in protein purification.
The ligands will be compared for their binding of BSA from a buffer 
solution and GST from the E. coli system developed in Chapters 3 and 5 
at high and low salt conditions and one will be chosen for further 
comparison studies with DEAE in Chapter 7.
6.2 Adsorbent Characteristics
Three high salt tolerant anion exchange ligands were evaluated for their 
binding capacity for both Bovine Serum Albumin (BSA) and Glutathione 
S-Transferase (GST). The structure of the multi-modal ligands is detailed 
in Figure 6.1 below.
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Figure 6.1: The chemical structures of the three prototype high salt tolerant anion 
exchange ligands.
The ligands were each attached to the newly developed high density 
STREAMLINE Direct adsorbent beads. These are cross-linked agarose 
beads modified by the inclusion of an inert stainless steel core material to 
provide a high density allowing for high flow velocities up to 900cm/hr. 
They are spherical with a particle size range of 80 to 165pm and a mean 
particle size and density of 135pm and 1.8g/mL respectively. A typical 
bead is shown in Figure 6.2.
Figure 6.2: The structure of a typical STREAMLINE Direct matrix bead (actual size is 
130(im). The dark matter is the stainless steel core material utilised to density the matrix 
allowing for high velocities.
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6.3 Purification of Bovine Serum Albumin
6.3.1 Without the addition of NaCl
BSA was prepared as described in 2.3.3.1 without the addition of NaCl. 
Purification was carried out in packed beds using the system described in 
2.3.3.2. The packed beds (described in 2.5) were filled with lOmL matrix 
corresponding to a 5cm bed height.
Feed was applied at a velocity of 100cm /hr until 90% breakthrough was 
reached at which the point the bed was washed and then the BSA was 
eluted. Breakthrough curves for the three ligands are shown in Figure 6.3. 
The total BSA in the elution fraction for the three ligands is quantified in 
Table 6.1.
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Figure 6.3: The breakthrough of BSA in lOmL packed beds loaded onto three 
prototype high salt tolerant ligands.
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6.3.2 With the addition of NaCl
BSA was prepared as described in 2.3.3.1 with the addition of 0.25M 
NaCl. Purification was carried out in packed beds using the system 
described in 2.3.3.2. The packed beds (described in 2.5) were filled with 
lOmL matrix corresponding to a 5cm bed height.
Feed was applied at a velocity of 100cm/hr until 90% breakthrough was 
reached at which the point the bed was washed and then the BSA was 
eluted. Breakthrough curves for the three ligands are shown in Figure 6.4. 
The total BSA in the elution fraction for the three ligands is quantified in 
Table 6.1.
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Figure 6.4: The breakthrough of BSA in the presence of salt in lOmL packed beds 
loaded onto three prototype high salt tolerant ligands.
104
Chapter 6: Prototype Ligand Evaluation
6.4 Purification of Glutathione S-Transferase
6.4.1 Without the addition of NaCl
GST from E. coli homogenate was prepared as described in 2.3.2.1 
without the addition of NaCl. Purification was carried out in packed beds 
using the system described in 2.3.2.2. The packed beds (described in 2.5) 
were filled with lOmL matrix corresponding to a 5cm bed height.
Each ligand was challenged with lOOmL of clarified E. coli homogenate 
containing approximately 3.5m g/m L GST. The feed was applied at a 
velocity of 100cm/hr. After loading the bed was washed and then the 
GST was eluted. Breakthrough curves for the three ligands are shown in 
Figure 6.5. The total GST in the elution fraction for the three ligands is 
quantified in Table 6.1.
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Figure 6.5: The breakthrough of GST in lOmL packed beds loaded onto three 
prototype high salt tolerant ligands.
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6.4.2 With the addition of NaCl
GST from E. coli homogenate was prepared as described in 2.3.2.1 with 
the addition of 0.2M NaCl. Purification was carried out in packed beds 
using the system described in 2.3.2.2. The packed beds (described in 2.5) 
were filled with lOmL matrix corresponding to a 5cm bed height.
Each ligand was challenged with lOOmL of clarified E. coli homogenate 
containing approximately 3.5mg/mL GST. The feed was applied at a 
velocity of 100cm/hr. After loading the bed was washed and then the 
GST was eluted. Breakthrough curves for the three ligands are shown in 
Figure 6.6. The total GST in the elution fraction for the three ligands is 
quantified in Table 6.1.
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Figure 6.6: The breakthrough of GST in the presence of salt in lOmL packed beds 
loaded onto three prototype high salt tolerant ligands.
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BSA (mg/ml) GST (mg/ml)
No Salt With Salt No Salt With Salt
Tris 52 16 16 9
DAB 57 18 18 16
DAP 50 22 20 12
Table 6.1: Total BSA and GST (mg/mL) captured on each prototype high salt ligand 
both with and without the presence of salt to adjust the conductivity. Numbers in bold 
highlight the highest capacity achieved for each product and conductivity level.
6.5 Discussion
The three prototype high salt tolerant ligands under investigation were 
developed to cope with high conductivity levels typical of fermentation 
broths (~20mS/cm) such that the need for feed dilution would be 
reduced. In addition to this, their performance at low conductivity levels 
should be similar or better than the performance of the currently 
available STREAMLINE DEAE. The structure of the ligands shown in 
Figure 6.1 would suggest that DAB and DAP may produce comparable 
results due to their structural similarity.
The breakthrough of BSA without the addition of salt is shown in Figure 
6.3 and it can be seen that the breakthrough curves are very similar for 
each ligand. It is also seen in Table 6.1 that the total BSA eluted from the 
matrix (mg BSA/mL matrix) is very similar for each ligand and is in 
excess of 50mg/ mL in each case. This compares well with STREAMLINE 
DEAE for which it is noted in the literature that the binding capacity for 
BSA should be in excess of 40mg BSA/mL adsorbent (Data File 
STREAMLINE SP/ STREAMLINE DEAE).
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With the addition of NaCl to the BSA feed to increase the conductivity 
level to ~25mS/cm it can be seen in Figure 6.4 that the breakthrough 
curves are again very similar for each ligand. If we compare these curves 
to those in Figure 6.3 it can been seen that breakthrough occurs earlier 
and is much steeper in the presence of salt, indicating that the binding 
performance will be reduced. This is confirmed with the total BSA bound 
shown in Table 6.1 where it can be seen that it has been reduced in the 
presence of higher salt levels for each ligand to 16 -  22 mg BSA/mL 
matrix.
If we now consider the breakthrough of GST without the addition of salt, 
shown in figure 6.5, we can see that the breakthrough curves for DAB 
and DAP are very similar, however the breakthrough on the Tris ligand 
occurs earlier and is much steeper. In addition to this, breakthrough 
levels achieved are in excess of 1.0 indicating that the GST is not the only, 
nor is it the most strongly, bound component of the feed and it is being 
displaced by some other component. Competitive displacement of 
adsorbed proteins has been described in model studies on competition 
between lysozyme and BSA when binding to similar adsorbents 
(Skidmore and Chase, 1990). If we then consider the total GST eluted 
from the matrices, quantified in Table 6.1, it can be seen that the Tris 
ligand binds the least GST as compared to DAB and DAP. The difference 
in GST bound (mg/mL) is not as extreme as may be expected by analysis 
of the breakthrough curves. This suggests that it may be more difficult to 
elute the GST from the DAB and DAP ligands than from the Tris ligand. 
In order to confirm this, the processes were mass balanced, data is shown 
in Table 6.2.
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Tris DAB DAP
No Salt With NaCl No Salt With NaCl No Salt With NaCl
Load 385 376 330 354 385 366
Flowthrough 217 279 94 151 106 163
Elution 158 88 183 156 200 120
In minus Out 10 9 53 47 79 83
Table 6.2: Total GST (mg) in each collected fraction for all three of the prototype 
ligands both with and without the presence of salt to adjust the conductivity. Numbers 
in bold highlight the quantity of GST that was lost in the process.
For the DAB ligand approximately 50mg GST was 'Tost" in the mass 
balance i.e. it was not possible to elute the full amount that had bound. 
The accuracy of the GST assay would only account for around 5mg of this 
thereby suggesting that the majority of the GST that was lost was due to 
the difficulty in eluting this protein from this ligand. Consequently this 
GST was then lost in the CIP. The DAP ligand retained 80mg GST after 
elution that was lost in the CIP.
With the addition of NaCl to the GST feed the breakthrough curves for 
the three ligands are now very similar, shown in Figure 6.6. If these 
curves are compared to those in Figure 6.5 it can be seen for the DAB and 
DAP ligands that the breakthrough occurs earlier and is much steeper, 
indicating that the binding performance will be reduced. This is 
confirmed with the total GST bound (m g/ mL) shown in Table 6.1 where 
the total GST bound has been reduced for each ligand. Once again the 
processes were mass balanced (shown in Table 6.2) and it was found that 
all the GST bound to the Tris ligand was eluted. Flowever DAB and DAP 
retained 50 and 80mg GST respectively that was lost in the CIP.
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Taking all of these results into account, the Tris ligand was disregarded 
for further experimental investigations as it did not bind the most BSA 
nor GST in any situation. In addition, the GST also appeared to be 
displaced by some other protein.
The performance of DAB and DAP was comparable, which was expected 
due to the similarities in their chemical structure. Careful analysis of their 
performance led to the choice of DAB for further studies. This was based 
on the fact that the highest level of GST was eluted from this ligand in the 
presence of salt, coupled with that fact that there was very little 
difference in the performance of this ligand at high or low salt 
concentrations. In addition it was easier to elute GST from DAB than 
from DAP.
6.6 Conclusions
The results from the packed bed experiments indicate that these 
prototype salt tolerant ion exchange ligands compare well w ith the 
currently available expanded bed matrix STREAMLINE DEAE. In 
particular DAB, which is to be used for further conductivity experiments, 
has a BSA capacity of 57m g/m L and a GST capacity of 18mg/mL.
This ligand will be used to investigate the effect of feed conductivity on 
the purification of GST from E. coli homogenate in Chapter 7 and the 
productivity implications will be considered in Chapter 8.
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Co n d u c tiv ity  o n  the  b in d in g  of 
G lutath io ne  S-T ransferase
7.1 Introduction
The effect of high conductivity levels in a fermentation broth on ion 
exchange chromatography frequently leads to the need to dilute the feed 
in order to reduce the ionic strength to such a level that allows binding of 
the target protein. Typically, this is in the 2-5 m S/cm  range and can 
require a 4-fold dilution. This is particularly problematic for expanded 
bed adsorption which is used early on in downstream processing as the 
feed volume is already at a process maximum straight out of the 
fermenter. A solution to this problem can be to use affinity ligands, 
however these are a very costly alternative. More recently, attention has 
focused on the use of multi-modal ligands that operate as ion exchangers 
at high salt concentrations. These have been developed for large-scale use 
and a high salt tolerant cation exchanger is now available commercially.
In Chapter 6 three high salt tolerant anion exchange ligands were 
evaluated for their performance when challenged with BSA and GST 
from E. coli homogenate both at high and low salt concentrations. The 
ligand DAB was chosen for further investigation into the effect of 
conductivity on the binding of GST. This chapter seeks to challenge this 
ligand in an expanded bed adsorption column with E. coli homogenate 
containing GST at a variety of conductivity levels. The DAB is coupled to 
new high density base matrix, STREAMLINE Direct to facilitate EBA 
operation at linear velocities in the range 300-900cm/hr.
The performance of the DAB matrix will be compared with that of the 
currently available STREAMLINE DEAE matrix. Furthermore, as the
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DAB ligand under investigation is coupled to a second generation 
expanded bed base matrix that is densified, allowing operation at 
velocities in the region of 300-900 cm /hr, the effect of this base matrix 
and of operating at high velocities will be investigated by comparison to 
a third adsorbent - DEAE coupled to the high density base matrix 
STREAMLINE Direct.
These three adsorbents will be challenged with the same feed at varying 
conductivity levels and their performance in terms of total GST bound 
compared. The relative productivity of each system will be considered in 
Chapter 8 with a view to determining the best possible process 
alternative for EBA application to high ionic strength feeds.
7.2 Adsorbent Verification and Characterisation
7.2.1 Purification of Bovine Serum Albumin
A new batch of STREAMLINE Direct DAB was produced specifically for 
this work and prior to commencing any GST purification runs, the 
adsorbent performance was verified by testing its capacity for BSA in a 
STREAMLINE 25 expanded bed column. BSA was prepared in buffer as 
described in 2.3.3.1 both without and with the addition of NaCl to 
increase the conductivity. The BSA was purified according to the 
methods in 2.4.2 using lOOmL matrix corresponding to a 20cm bed 
height. The operating velocity was chosen in order to achieve double 
expansion, this was found to be 600cm/hr. Feed was applied until 90% 
breakthrough was reached at which point the bed was washed and the 
BSA was eluted in an upwards direction. The elution fraction was 
collected and analysed for BSA concentration.
The BSA dynamic capacity at 90% breakthrough without salt was found 
to be 46 compared with 57 mg BSA/ mL matrix in the packed bed. In the 
presence of salt (0.25M NaCl with a corresponding conductivity level of
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25mS/cm), this was reduced to 20 (at 97% breakthrough) compared with 
18 mg BSA/mL matrix (at 90% breakthrough) in the packed bed.
7.2.2 Adsorption Isotherm for GST
In order to further characterise this matrix, the adsorption isotherm for 
GST was produced as described in 2.6.10 by challenging samples of 
matrix with E. coli that was clarified and disrupted as described in 2.3.2.1 
containing varying concentrations of GST. The GST concentrations varied 
between 0 - 4m g/ mL such that the highest concentration far exceeded the 
GST levels produced in the fermentation (typically 1.5mg GST/mL). The 
isotherm in shown in Figure 7.1.
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Figure 7.1: The adsorption isotherm for binding of GST from £. coli homogenate to the 
prototype STREAMLINE Direct DAB. Cm is the concentration of GST (mg/mL) in the 
applied sample and Cs is the amount of GST (mg) bound to the matrix (mL).
7.2.3 Determination of Feed Volume for Conductivity 
Investigations
In order to establish the volume of feed to be used in each experiment, 
the STREAMLINE Direct DAB was loaded with E. coli homogenate to 
determine the quantity of feed containing GST required to achieve 10%
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GST breakthrough. The feed was prepared as described in 2.3.2.1 and the 
GST was purified according to the methods in 2.4.2.2 and the buffer 
system described in 2.3.2.2. A typical breakthrough curve is shown in 
Figure 7.2.
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Figure 7.2: The breakthrough of GST from whole £. coli homogenate loaded at 
600cm/hr on lOOmL STREAMLINE Direct DAB in a STREAMLINE 25 EBA column at a 
conductivity of 20mS/cm.
The breakthrough occurred much earlier than expected and rose very 
dramatically. The total GST eluted was found to be lm g  GST/mL matrix 
and only 1% of the applied GST was recovered. This was in contrast to 
the 16mg GST/mL matrix found in the packed bed experiments. Upon 
consideration, it was hypothesised that there may be some entity in the 
fermentation broth that was binding more strongly to the matrix than the 
GST. This hypothesis was reinforced when considering the conditions of 
feed preparation between the packed bed and expanded bed systems. For 
the packed bed experiments, the E. coli broth was clarified and the pellet 
then resuspended in buffer for disruption. This disrupted sample was
114
Chapter 7: Conductivity Investigation
then clarified to prevent loading of debris onto the packed bed. In the 
case of the expanded bed, the E. coli broth was disrupted and loaded 
directly onto the bed after pH adjustment. For the packed bed 
preparation this effectively removed the fermentation broth and its 
components from the feed loaded onto the column, whereas these 
remained in the feed loaded onto the expanded bed.
In order to test the hypothesis that some component(s) in the 
fermentation broth that remained in the EBA feed led to the reduction in 
capacity for GST, the E. coli broth was clarified as per 2.2.2. The cell broth 
supernatant was adjusted to pH 8.5 and loaded onto the expanded bed. 
The cell broth supernatant was found to contain lm g / mL GST. The cell 
pellet was resuspended in buffer for disruption. After disruption the pH 
was adjusted to 8.5 and this homogenate was loaded onto the expanded 
bed. Breakthrough curves are shown in Figures 7.3 and 7.4 for cell broth 
supernatant and homogenised pellet respectively.
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Figure 7.3: The breakthrough of GST found in the £. coli broth supernatant loaded at 
600cm/hr on lOOmL STREAMLINE Direct DAB in a STREAMLINE 25 EBA column at a 
conductivity of 20mS/cm.
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Figure 7.4: The breakthrough of GST from the disrupted E. coli cell pellet loaded at 
600cm/hr on lOOmL STREAMLINE Direct DAB in a STREAMLINE 25 EBA column at a 
conductivity of 20mS/cm.
When the cell broth supernatant was applied it was found that the total 
GST eluted was 0.6mg GST/mL matrix with 2% of the applied GST being 
recovered in the elution. When the disrupted pellet was loaded it was 
found that the total GST eluted was 8mg GST/mL matrix with 55% of the 
applied GST recovered in the elution. These results support the 
hypothesis that there was some entity in the fermentation broth 
preventing GST binding. As such, for further purifications, the E. coli 
broth was clarified as per 2.2.2 and the pellet resuspended in buffer for 
disruption.
From Figure 7.4 it was established that 700mL of clarified and disrupted 
E. coli with a GST concentration of 0.8mg/mL (±10%) and a conductivity 
level of 20mS/cm would be needed to achieve 10% GST breakthrough on 
the STREAMLINE Direct DAB. This provided the base-line for the next 
phase of studies.
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7.3 Conductivity Studies
In the previous section, it was established that 700mL of undiluted, 
clarified and disrupted E. coli containing 0.8mg/ mL GST at a 
conductivity level of 20mS/cm was needed to achieve 10% GST 
breakthrough on the STREAMLINE Direct DAB adsorbent. This feed was 
prepared and loaded onto the three adsorbents under investigation:
1. STREAMLINE Direct DAB
2. STREAMLINE DEAE
3. STREAMLINE Direct DEAE
For each adsorbent, the flowrate was chosen such that the matrix height 
upon expansion in equilibration buffer was double that of the settled bed 
height (20cm for each adsorbent). This was found to be 600cm /hr for the 
STREAMLINE Direct adsorbents and 160cm/hr for the STREAMLINE 
DEAE.
To investigate the effect of conductivity the feed prepared as described 
above was diluted with equilibration buffer as appropriate to reduce the 
conductivity to 10 and 2.5mS/cm i.e. 1 in 2 and 1 in 8 dilutions 
respectively. The breakthrough curves at each conductivity level are 
shown in Figure 7.5 and the total GST collected in the elution is 
summarised in Table 7.1.
20mS/cm lOmS/cm 2.5mS/cm
STREAMLINE Direct DAB 482 516 495
STREAMLINE Direct DEAE 140 461 431
STREAMLINE DEAE 328 541 562
Table 7.1: The total GST (mg) eluted at each conductivity level (20,10 and 2.5 mS/cm) 
and from lOOmL of each adsorbent (STREAMLINE Direct DAB, STREAMLINE DEAE 
and STREAMLINE Direct DEAE).
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Figure 7.5: The breakthrough of GST from disrupted E. coli loaded onto lOOmL of the 
three adsorbents (STREAMLINE Direct DAB, STREAMLINE DEAE and STREAMLINE 
Direct DEAE) at three conductivity levels (20, 10 and 2.5 mS/cm) and a velocity of 
600cm/hr for the STREAMLINE Direct adsorbents and 160cm/hr for the STREAMLINE 
DEAE.
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Figure 7.5a: GST breakthrough when loaded at a conductivity level of 20mS/cm.
0 .1 2  -i o o
0 .1 0 -
0.08-
- O '-O"
u °  0 .06- 
u
0.04-
A SL Direct DAB 
—■— SL Direct DEAE 
o sl DEAE
0 .0 2 -
0.00
0 200 400 600 800 1000 1200 1400
Total Volume Applied, mL
Figure 7.5b: GST breakthrough when loaded at a conductivity level of lOmS/cm.
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Figure 7.5c: GST breakthrough when loaded at a conductivity level of 2.5mS/cm.
7.4 Discussion
The new batch of STREAMLINE Direct DAB was tested in an expanded 
bed for its binding capacity to BSA prepared in buffer. As this was a 
prototype adsorbent, no standard operating procedures were in place for 
large scale production of the base matrix or ligand coupling and therefore 
testing was required to ensure its performance was comparable with that 
of the small volume samples evaluated in Chapter 6. The results 
compared well with those observed in the packed bed. W ithout the 
addition of NaCl, the dynamic capacity at 90% breakthrough was slightly 
reduced in the expanded bed compared w ith the packed bed from 57 to 
46mg BSA/mL matrix. This reduction in the capacity is to be expected 
with expanded beds and is due to the reduction in NTP observed in 
expanded beds. This leads to shallower breakthrough curves in expanded 
beds as compared to the packed beds. This then coupled with the 
increase in operating velocity which limits the mass transfer as observed 
in Chapters 4 and 5 leads to lower binding capacities. With the addition 
of salt to increase the conductivity, the dynamic capacity was found to be
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20mg BSA/mL matrix at 97% breakthrough in the expanded bed, 
compared with 18mg BSA/ml matrix in the packed bed. The slightly 
higher dynamic binding capacity observed in the expanded bed can be 
attributed to the fact the breakthrough in the packed bed only reached 
90%. The dynamic binding capacity at 90% in the expanded bed was 
calculated based on the breakthrough curves. This was found to be 
15mg/mL and therefore is consistent with the packed beds results 
coupled with the reduced capacity in the expanded bed, discussed above.
In order to test further this new batch of DAB adsorbent and to 
understand the binding of GST to DAB, the adsorption isotherm was 
prepared. It can be seen in Figure 7.1 that the isotherm in the 
concentration range tested is linear. The GST concentrations applied to 
the matrix for preparation of the isotherm (0 -  4m g/m L GST) were such 
that they far exceeded the concentrations produced in the fermentation 
(1.5mg/mL GST) and as such the concentration that would be applied to 
the expanded bed. The implications of this linear adsorption isotherm are 
that maximum capacity of the adsorbent has not yet been reached.
After this initial testing, it was concluded that the new batch of 
STREAMLINE Direct DAB was behaving as expected both with BSA and 
GST. The next stage was to determine the quantity of GST and hence 
volume of feed to be applied to each of the three adsorbents under 
investigation. It was decided that the quantity of GST applied should be 
such that the GST had reached 10% breakthrough on the STREAMLINE 
Direct DAB.
In order to establish this, whole E. coli fermentation broth was disrupted 
and the pH adjusted to 8.5 and this was loaded onto the STREAMLINE 
Direct DAB matrix in the expanded bed. The resulting breakthrough 
curve is shown in Figure 7.2. Based on experiences in the packed bed, the 
breakthrough occurred much faster than anticipated, going from 0% at 
200mL applied feed volume to 70% GST breakthrough at 500mL applied
120
Chapter 7: Conductivity Investigation
volume. The process was mass balanced and it was found that only 1 % of 
the applied GST was recovered in the elution, equivalent to a dynamic 
binding capacity of lm g  GST/mL matrix. This was in contract to the 
16mg GST/  mL matrix obtained in the packed bed.
Given that this batch of matrix had successfully bound GST in the 
isotherm experiments, the feed preparation method was examined. For 
both the packed bed and isotherm experiments, the £. coli fermentation 
broth was clarified and the supernatant discarded. The pellet was then 
resuspended in buffer prior to disruption. For the expanded bed 
experiment, the whole fermentation broth was disrupted. This indicated 
the possibility that there may be some entity in the supernatant that was 
binding more strongly to the matrix than the GST.
To test this theory, supernatant was loaded onto the expanded bed. 
Despite GST being an intracellular protein, the supernatant was found to 
contain lm g /m L  GST. This was most likely due to partial cell lysis 
during the freezing process. In this test, only 2% of the applied GST was 
recovered in the elution, equivalent to a dynamic binding capacity of 
0.6mg GST/ mL matrix.
E. coli was then clarified and the supernatant discarded. The cell pellet 
was resuspended in buffer, disrupted, and the pH adjusted to 8.5 prior to 
loading onto the expanded bed. In this case, 55% of the applied GST was 
recovered with a dynamic binding capacity of 8mg GST/  mL matrix. This 
compared more favourably w ith the packed bed results.
These tests indicated that GST binding was suppressed in the presence of 
cell broth supernatant. The colour and odour of the elution fraction when 
the bed was loaded with supernatant suggested that the competitive 
entity may be some component of the yeast extract, a highly complex 
organic nitrogen source containing a variety of vitamins, minerals and 
other growth factors. This has been observed in other studies (Calado et 
al 2002).
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When the cell pellet minus the cell broth supernatant was used for feed 
preparation, the capacity for GST in the expanded bed was half that 
observed in the packed bed. This decrease was to be expected for the 
reasons outlined above when comparing the capacity for BSA.
From these tests it was established that 700mL of feed containing 
0.8mg/mL GST prepared from disrupted £. coli cell pellet w ith a 
conductivity of 20mS/cm would be needed to reach 10% GST 
breakthrough on the STREAMLINE Direct DAB. In an industrial process 
the fermentation broth would typically not be clarified prior to disruption 
if an EBA step was to be utilised. However since the purpose of this 
study was to compare binding performance of these adsorbents w ith the 
given feed no further fermentation development was considered to 
evaluate the interaction w ith DSP.
Instead, the common feed was loaded onto equal volumes of lOOmL of 
each of the three adsorbents under study such that they were each 
challenged with the same total quantity of GST. The breakthrough curves 
are shown in Figure 7.5a. From these curves it can be seen that the 
STREAMLINE Direct DAB reaches the lowest overall breakthrough. The 
two DEAE adsorbents reach high levels of breakthrough rapidly, with the 
STREAMLINE Direct DEAE reaching the highest overall breakthrough. 
The results are further quantified in Table 7.1 where it can be seen that 
the STREAMLINE Direct DAB binds the most GST (482mg), followed by 
the STREAMLINE DEAE (328mg) with the STREAMLINE Direct DEAE 
binding the least GST (140mg). As the DEAE ligand is not designed to 
operate at high conductivity levels, these results are in-line with 
expectations.
The difference in the total GST bound by the two DEAE adsorbents can 
be attributed to the effect of operating velocity. The total GST bound by 
the STREAMLINE DEAE adsorbent loaded at a velocity of 160cm/hr is 
double that bound by the STREAMLINE Direct DEAE, loaded at a
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velocity of 600cm/hr. This increase in velocity leads to a reduction in 
contact time which in a mass transfer limited situation will lead to a 
reduction in dynamic binding capacity.
In the subsequent experiments, conductivity of the feed was then reduced 
to lOmS/cm by dilution of the original 700mL feed w ith 700mL of 
equilibration buffer. Breakthrough curves at this conductivity level can be 
seen in Figure 7.5b. At this conductivity level, the behaviour of the three 
adsorbents is comparable, not only in terms of breakthrough curves, but 
also in the total GST bound, summarised in Table 7.1.
Comparing the behaviour of the three adsorbents at this conductivity 
level with that at the higher conductivity level of 20mS/ cm, it can be seen 
that there is no difference in performance for the STREAMLINE Direct 
DAB adsorbent. The performance of the two DEAE adsorbents has 
improved with a reduction in the conductivity and their behaviour is 
now comparable with that of the STREAMLINE Direct DAB. Again, as 
observed at the higher conductivity level, the STREAMLINE DEAE 
adsorbent outperforms the STREAMLINE Direct DEAE. This is most 
likely due to the difference in operating velocities, discussed above.
A further reduction in the conductivity level to 2.5mS/ cm by dilution of 
the original feed with 4900mL equilibration buffer does not offer any 
obvious advantage in terms of the performance and behaviour of the 
three adsorbents. If the results at this conductivity level are compared 
with those at 10mS/ cm, it can be seen that both the breakthrough curves 
in Figure 7.5c and the total GST bound detailed in Table 7.1 are very 
similar in shape and that the differences in amount of GST bound are 
now small relative to saturation levels.
Taken together, these results demonstrate that the STREAMLINE Direct 
DAB performs consistently in the range of conductivities tested. In order 
for the DEAE ligand to bind similar quantities of GST, the conductivity 
must be halved.
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7.5 Conclusions
The multi-modal ligand DAB was designed to operate at high 
conductivity levels typical of fermentation broths (approximately 
20mS/cm). As these experiments indicate, this ligand performed 
consistently in the range of conductivity levels tested (2.5 -  20mS/cm). Its 
performance was comparable with that of the commercially available 
DEAE ligand at low conductivity levels where the latter ligand is 
designed to be optimal.
As expected the performance of the DEAE ligand was reduced at high 
conductivity levels. The dilution required for acceptable performance 
was 1 in 2, reducing the conductivity to 10mS/ cm. At this conductivity 
level, performance was comparable with that of DAB ligand at 20mS/ cm.
The STREAMLINE Direct DEAE was consistently outperformed by the 
STREAMLINE DEAE adsorbent at all conductivity levels. This was due 
to the operating velocity in each of these systems. The STREAMLINE 
Direct DEAE was operated at a velocity of 600cm/hr, 3.75 fold higher 
than that of the STREAMLINE DEAE (160cm/hr). This increase in 
velocity led to an accentuation of mass transfer limitations and a 
reduction in the contact time.
The full implications of these observed differences in ligand behaviour 
and the effect of the base matrix and ligand design on the productivity of 
each adsorbent will be considered in the next chapter.
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V a r y in g  O p e r a t in g  P a r a m e t e r s  a n d  M a t r ix  
Pr o pe r t ie s
8.1 Introduction
In Chapters 4 and 5, the effect of matrix particle size distribution and 
operating velocity on protein binding in an expanded bed was examined. 
It was found for both systems under study that when operating at 
velocities typically utilised in EBA, no benefit in terms of performance 
was offered through careful selection of the particle size distribution in 
the range of sizes commercially available.
In Chapter 7, the effect of conductivity was considered on protein 
binding to three adsorbents, different in both their ligand chemistry and 
their base matrix. The multi-modal ligand was found to operate most 
effectively at high conductivity levels, thereby reducing the need to dilute 
the feed. The performance of the commercially available ligand DEAE 
was improved by operating at low velocities.
In all of these studies, performance was examined only in terms of the 
product breakthrough. The overall productivity of each scenario was not 
considered. Productivity can be defined and expressed in a variety of 
forms, ranging from the simple, where for example processing time is 
considered, to the complex, where time, buffer, matrix and costs are 
considered. In industry, productivity is a key parameter as ultimately, no 
matter what its definition, an improvement in the productivity of the 
overall process leads to cost benefits.
This chapter seeks to examine a number of productivity definitions using 
the Yeast/ADH system investigated in Chapter 4 to illustrate their 
meaning. This will provide the basis for a productivity definition that will
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be used to evaluate all of the processes examined in this thesis. In order to 
provide a realistic productivity expression, this definition will be based 
on the total ADH recovered in the elution fraction. However as no elution 
development was carried out in this thesis, 100% product recovery in the 
elution is unlikely. Instead it will be assumed for comparison only that 
the breakthrough curves can be integrated for the Yeast/ADH processes 
in order to calculate the total quantity of product bound. Furthermore, 
the 5% dynamic binding capacity will be calculated for each of the 
Yeast/ ADH processes as a reflection of the likely levels to be encountered 
in processing. Productivity levels can be evaluated based on these 
figures.
8.2 Productivity Definition Evaluation
The Yeast/ ADH system examined in Chapter 4 considered the impact of 
operating velocity and matrix particle size on the HIC purification of 
ADH from unclarified Yeast homogenate. Results in terms of 
breakthrough curves indicated that no benefit was offered by careful 
selection of matrix particle size distribution at flowrates typical of an EBA 
process (300cm/hr).
The impact of increasing operating velocity offers savings in terms of 
processing time, but the trade off is that buffer consumption is higher. 
The smaller matrix particles expand more than the larger particles at a 
given velocity and so require longer processing times and higher buffer 
consumption. Taking this into consideration, the Yeast/ ADH processes 
were re-examined in terms of their buffer consumption and processing 
time, as shown in Figure 8.1.
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Figure 8.1: The trade off between buffer consumption (mL) and processing time (min) 
when varying the operating flowrate and matrix particle size.
Whilst Figure 8.1 clearly illustrates the trade off between buffer 
consumption and processing time, the most critical parameter is the 
quantity of product that is recovered in the elution for further processing. 
If we now consider this in terms of buffer consumption and processing 
time, Figure 8.2 is the resulting graph.
A useful way of considering the effect of both operating velocity and 
matrix particle size is the residence time concept introduced in Chapter 4. 
If we now consider the total ADH recovered as a function of the tR, 
described in 2.6.7, defined in equation 2.4 and evaluated for the 
Yeast/ ADH processes in Table 4.3, this yields Figure 8.3.
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Figure 8.2: The trade off between buffer consumption and processing time in relation 
to the total ADH recovered in each process.
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Figure 8.3: The effect of residence time, fj?, a measure of operating velocity and matrix 
particle size distribution on the total ADH recovered for each system set-up based on 
particle size and operating velocity.
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Whilst the productivity may be defined as Units of ADH per mL buffer 
consumed per min processing time in order to compensate for the trade­
off between buffer consumption and processing time, it is very much a 
process-specific definition. If we consider the buffer consumption, only 
processes that utilise the same buffers can be compared using this 
expression, as the cost and hence significance of buffer consumption will 
be directly related to the buffers utilised in the process.
However, if processing time can be reduced with the same quantity of 
product recovered, this would be a very attractive proposal. For example, 
if the downstream processing for product X can be reduced from 5 to 4 
days whilst maintaining the same product quantity and quality, and if we 
assume that the processing plant is operational for 80% of the year, 73 
batches of product can be produced for the 4 day process compared with 
58 batches for the 5 day process -  a 26% increase.
As the total product recovered per processing time is a simple yet 
meaningful and relevant measure of productivity, it will be used to 
evaluate the processes investigated in this thesis. This will be compared 
with the productivity calculated based on total product bound from 
integration of the breakthrough curves and the total product bound at 5% 
breakthrough for the Yeast/ ADH processes.
It should be noted that such a productivity evaluation is limited to similar 
processes such that their costs are approximately equivalent -  which is 
the case here. However, if the processes under comparison were 
different, for instance in the above example the total processing time may 
be reduced by employing alternative DSP, it would be advisable to assign 
costs to the various parameters of the process in order to better 
understand the benefit, or indeed possibly the loss, that the reduction in 
time may confer.
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8.3 Productivity Evaluation of the ADH Process
The productivity of the Yeast/ ADH process investigated in Chapter 4 is 
summarised in Table 8.1 detailing the total ADH recovered in each 
process (Units) and each of the process residence times (tR, sec) and the 
corresponding total processing time, including the load, wash and elution 
time.
Process tR/
sec
ADH recovered, 
Units
Processing 
Time, min
Productivity, Units 
ADH recovered/min
Large, lOOcm/hr 485 72,458 82 889
Small, lOOcm/hr 658 69,637 86 810
Large, 300cm/hr 333 47,170 47 1,014
Small, 300cm/hr 414 55,560 53 1,058
T a b le  8.1: The productivity defined as the total ADH recovered (Units) in the elution 
fraction per minute of processing time for each of the Yeast/ ADH processes.
The breakthrough curves for the Yeast/ADH processes in Chapter 4, 
Figures 4.3 b and c were integrated to evaluate the total ADH bound to 
the matrix and then integrated to calculate the total ADH bound at 5% 
breakthrough and the productivity re-evaluated based on these. This is 
summarised in Tables 8.2 and 8.3 for the total ADH bound in the process 
and the total ADH bound at 5% breakthrough respectively.
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Process for
sec
ADH bound, 
Units
Processing 
Time, min
Productivity, Units 
ADH bound/min
Large, lOOcm/hr 485 76,132 82 934
Small, lOOcm/hr 658 73,168 86 851
Large, 300cm/hr 333 77,161 47 1,659
Small, 300cm/hr 414 78,346 53 1,492
Table 8.2: The productivity defined as the total ADH bound (Units) based on 
breakthrough curve integration per minute of processing time for each of the 
Yeast/ADH processes.
Process
sec
ADH bound 
(5% ), Units
Processing 
Time, min
Productivity, Units 
ADH bound (5 % )/min
Large, lOOcm/hr 485 32,258 60 538
Small, lOOcm/hr 658 55,628 73 762
Large, 300cm/hr 333 55,526 41 1,354
Small, 300cm/hr 414 58,852 48 1,239
Table 8.3 : The productivity defined as the total ADH bound at 5% product 
breakthrough (Units) per minute of processing time for each of the Yeast/ADH  
processes.
8.4 Productivity Evaluation of the GST Process
For the E. coli/GST  process various operating parameters were 
investigated; in Chapter 5, the effect of operating velocity was considered 
on the binding of GST and in Chapter 7 the effect of feed conductivity 
was considered.
Also, various matrix properties were considered in the investigations; in 
Chapter 5 the matrix particle size was considered and in Chapter 7 the 
ligand and base matrix was investigated.
The different processes have been summarised separately below.
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8.4.1 Velocity and Particle Size Distribution Effects
The productivity of the E. coli/GST process investigated in Chapter 5 is 
summarised in Table 8.4 detailing the total GST recovered in each process 
(mg) and each of the process residence times (£r , sec) and the 
corresponding total processing time, including the load, wash and elution 
time.
Process t*/
sec
Total GST 
recovered, mg
Processing 
Time, min
Productivity, 
mg GST/min
Large, lOOcm/hr 583 77 169 0.46
Small, lOOcm/hr 615 77 180 0.43
Large, 300cm/hr 344 58 71 0.81
Small, 300cm/hr 385 68 78 0.87
Table 8.4: The productivity defined as the total GST recovered (mg) per minute of 
processing time for each of the E. c o l i / G S T  processes where the effect of operating 
velocity and particle size distribution was investigated.
8.4.2 Conductivity Effects
The productivity of the E. coli/GST  process investigated in Chapter 7 is 
summarised in Table 8.5 detailing the total GST recovered in each process 
(mg) and each of the process residence time (£r , sec) and the 
corresponding total processing time, including the load, wash and elution 
time.
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Cond.
mS/cm
Matrix tR,
sec
Total GST 
recovered, mg
Processing 
Time, min
Productivity, 
mg GST/min
20
SL Direct DAB 180 482 30 15.85
SL Direct DEAE 185 140 37 3.75
SL DEAE 570 328 126 2.6
10
SL Direct DAB 180 516 46 11.17
SL Direct DEAE 185 461 46 9.99
SL DEAE 570 541 170 3.18
2.5
SL Direct DAB 180 495 129 3.84
SL Direct DEAE 185 431 129 3.34
SL DEAE 570 562 285 1.97
Table 8.5: The productivity defined as the total GST recovered (mg) per minute of 
processing time for each of the E. c o l i / G S T  processes investigated in terms of 
conductivity effects.
8.5 Discussion
There are a variety of ways of defining and calculating process 
productivity. This chapter set out to evaluate various options using the 
Yeast/ ADH process developed in Chapter 4 as an example. Productivity 
is ultimately related to cost. As such, those parts of the process that cost 
money were initially evaluated; these were the processing time and 
buffer consumption. The effect of increasing velocity and varying matrix 
particle size distribution on the buffer consumed and the processing time 
is shown in Figure 8.1. As can be seen in this Figure, increasing the 
operating velocity leads to shorter processing times but increases the 
buffer utilised in the process. At each flowrate, the large particles 
required less processing time and buffer than the small particles. This is 
due to the small particles expanding more than the large particles at a 
given flowrate and thus should be expected and is predictable.
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If we further examine this graph and choose the point at which the buffer 
consumption and processing time are both at a minimum, this would 
lead to the conclusion that the large particles operated at a velocity of 
around 160cm/hr would be the most productive option.
However whilst this choice may minimise processing costs in terms of 
buffer consumption and processing time, the quantity of revenue 
generating product, in this case the ADH, has not been considered. If we 
now examine Figure 8.2 which illustrates the effect of increasing the ADH 
recovered on buffer consumption and processing time, it can be seen that 
at the maximum quantity of ADH recovered, buffer consumption is at its 
minimum, but processing time is close to the maximum. As relative costs 
have not been associated with the buffer consumption, processing time 
and ADH, it is difficult to conclude whether this would be the most 
productive and as such this would be an area of further work. With such 
data it would be possible to determine the precise optimum point of 
operation for any set of relative operational parameters.
An alternative method that indirectly considers both the buffer 
consumption and processing time is to examine the effect of tR on the 
total ADH recovered. As the buffer consumption and processing time are 
directly affected by the matrix particle size distribution and operating 
velocity, as illustrated in Figure 8.1, utilising the tR concept introduced in 
Chapter 4 allows us to consider these effects on the ADH recovered. This 
can be seen in Figure 8.3 where it is clear that increasing the residence 
time by lowering the flowrate leads to benefits in total ADH bound up 
until a tR of ~480secs at which point there is no improvement in the 
recovery. Taking this into consideration, a possible interesting area of 
study would be to modify the operating velocity and particle size 
distribution such that the residence time is 480secs and then attempt to 
optimise the process in terms of buffer consumption and processing time.
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As outlined above, no costs have been associated with the buffer 
consumption, processing time and product. W ithout these for each of the 
processes, it is difficult to evaluate accurately and compare the 
productivity. This is especially true if buffer costs are low in relation to 
product value and processing time. As all production companies 
understand processing time, its use in a productivity expression defined 
as the total product recovered per minute of processing time provides a 
simple yet meaningful measure of process productivity. As such, the 
productivity for each process investigated in this thesis was calculated 
and results are shown in Tables 8.1 -  8.5.
If we consider the results in Table 8.1 for the ADH process, it can be seen 
that the most productive option is to utilise the small particles at a 
flowrate of 300cm/hr; the least productive option is the small particles at 
lOOcm/hr. At the low flowrate, for both of the matrix particle sizes the 
whole process takes much longer than at the high flowrate. This is 
increased even further for the small particles due to the increase in 
expansion experienced with this particle size at the same flowrate. This is 
coupled with the increase in residence time offering no advantage in 
terms of ADH recovered.
At the high flowrate, the small particles are more productive than the 
large particles. Whilst the overall processing time is longer for the small 
particles due to the increased bed expansion, this increase in expansion 
provides a longer residence time and hence more time for product 
binding. Therefore the increase in processing time is compensated for by 
the increase in overall ADH recovered leading to a more productive 
process.
If we now consider the productivity of these processes based on the total 
ADH bound, calculated from the breakthrough curves (Table 8.2) it can 
be seen that the most productive process is the large particles operated at 
300cm/hr. The least productive is the small particles operated at
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lOOcm/hr. The small particles at the low velocity is the least productive 
for the same reasons discussed above when considering the productivity 
based on the total ADH recovered. However, the most productive option 
is to use large particles and to operate at the highest flowrate. This 
contrasts to the results based on ADH recovered where the choice is to 
use small particles at the high flowrate. This is due to the similarity in 
levels of ADH bound for both particle sizes at the higher flowrate, as 
expected based on the breakthrough curves. The large particles require a 
shorter processing time based on their lower expansion characteristics. 
The resulting large particle productivity is higher compared to that for 
the small particles.
In this thesis, for each process, the performance of each matrix was 
compared when challenged with the same total quantity of product. This 
was due to the difficulty in controlling the load volume for a specific 
breakthrough level. In an industrial process it would be unlikely that 
product would be loaded to more than 5-10% breakthrough dependent 
on its value, as this would lead to unacceptable product losses. To mimic 
this, the breakthrough curves for the Yeast/ADH processes were 
evaluated to calculate the ADH bound at 5% breakthrough, and the 
processing times noted at the point at which this quantity of feed was 
loaded. When the productivity is evaluated on this basis, the least 
productive option is to use the large particles at lOOcm/hr and the most 
productive is the large particles at 300cm/hr.
Despite the smaller particles operated at the lower velocity taking longer 
to process a given feed volume than the large particles, their dynamic 
binding capacity at 5% is higher. This is due to the higher specific surface 
area offered by these particles, which leads to a higher productivity. This 
would be expected when comparing the breakthrough curves in Chapter 
4 Figure 4.4b where it can be seen that the small particles have a much 
shallower breakthrough curve than the large particles.
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At the higher velocity, where the large particles are more productive than 
the small particles, the result is most likely due to the large particles 
taking less time to process, coupled with the similarity in performance at 
the higher velocity due to mass transfer limitations. This is to be expected 
based on the breakthrough curves (Chapter 4 Figure 4.4c)
From these analyses it appears that the most realistic value to use in all 
the cases is the actual ADH recovered as it is the actual quantity of ADH 
obtained from the EBA stage that would be used in any further 
processing strategies. As such, the productivity evaluation for the 
remaining systems in this thesis are based on the product recovered in 
each of the processes.
The productivity of the E. coli/ GST system when investigating the effects 
of particle size and operating velocity, follows similar trends to the 
Yeast/ADH system. The least productive option is the small particles at 
lOOcm/hr and the most productive is the small particles at 300cm/hr. It 
can also be seen that increasing the residence time leads to an increase in 
the overall GST recovered up until a residence time of ~580secs. Whilst 
this is a higher residence time than that of the ADH process, it should be 
noted that the residence time for the GST system was based on more 
complete penetration of the matrix particles. For the ADH process it was 
based on surface area only. As such, a higher residence time should be 
expected for the GST system as compared w ith the ADH system.
Despite the difference in the GST and ADH systems in terms of the both 
the chromatographic method used and the size of the molecules (leading 
to surface binding and full penetration for the ADH and GST 
respectively) similar conclusions for both systems have been reached in 
terms of the effect of matrix particle size and operating flowrate on the 
performance and productivity indicating that the results from this work 
are transferable.
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If we now consider the effect of conductivity on the productivity of three 
adsorbents, summarised in Table 8.3, it can be seen that overall, the most 
productive option is the STREAMLINE Direct DAB matrix at a 
conductivity of 20mS/ cm; the least productive option is the 
STREAMLINE DEAE at 2.5mS/cm.
If we consider the three adsorbents in turn, it can be seen for the 
STREAMLINE Direct DAB that the productivity decreases as the 
conductivity decreases. This is to be expected as the total GST bound at 
each conductivity level was comparable and as such, a reduction in the 
conductivity led directly to a larger feed volume due to the required feed 
dilution and consequently this led to a longer processing time.
For the STREAMLINE Direct DEAE and the STREAMLINE DEAE, at the 
highest conductivity level (20mS/ cm) the productivity is low due to the 
inability of the DEAE ligand to operate at high conductivity levels. When 
the conductivity is reduced to 10mS/ cm the productivity improves as the 
ligand is able to function at this conductivity level. The productivity then 
drops as the conductivity is further reduced due to the larger feed 
volume leading to an increase in the processing time coupled w ith no 
improvement in the total GST bound. This result is an interesting 
example of the competitive processes that control overall behaviour.
The impact of the new densified base matrix, STREAMLINE Direct, leads 
to improvements in the overall productivity. If we compare the 
STREAMLINE Direct DEAE with the STREAMLINE DEAE, it can be seen 
that despite the STREAMLINE DEAE binding more GST at each 
conductivity level, the productivity is lower due to the lower operating 
velocity.
If we then combine this base matrix with the prototype multi-modal DAB 
ligand that can operate at high conductivity levels, the productivity is 
further improved as the need to dilute the feed to reduce the conductivity 
is eliminated.
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If we assume that the process of choice with the commercially available 
STREAMLINE DEAE ligand would be to run at 10mS/ cm, the 
productivity in this scenario is 3.18 mg GST/min processing time. If we 
now assume that the process of choice if using the prototype 
STREAMLINE Direct DAB would be to run at 20mS/ cm, the productivity 
for this process is 15.85 mg GST/  min processing time -  a 5 fold increase. 
This demonstrates that the use of the prototype STREAMLINE Direct 
DAB matrix offers significant benefits in terms of the productivity 
improvements available.
8.6 Conclusions
The analyses within this chapter have led to the use of process 
productivity being defined as total product recovered per min of 
processing time. This is a simple yet meaningful definition of 
productivity that can be applied to any process and is not limited to EBA.
If we consider the EBA processes investigated in this thesis, the impact of 
increasing the operating flowrate leads to improvements in productivity 
when defined as above as this leads to shorter processing times.
If the impact of matrix particle size is also considered, the most 
productive for both the ADH and GST systems is the use of small 
particles at the higher flowrate.
Conversely, the least productive is also the use of small particles at low 
flowrates. It has been observed that increasing the overall residence time 
will only offer improvements in total product bound up to a point, 
beyond which the additional time is not matched by a comparable rise in 
product bound.
When comparing the prototype high salt tolerant ligand coupled to a new 
densified base matrix w ith the commercially available STREAMLINE 
DEAE adsorbent, the productivity can be improved 5 fold.
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The overall implications of the work in this thesis will be discussed in the 
next chapter and areas of further work will also be considered. The 
regulatory and commercial implication of EBA will then also be 
examined.
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The aims of this study were to investigate the effects of various matrix 
properties and operating parameters on the product breakthrough 
behaviour in an expanded bed adsorption column and to investigate the 
result of these effects on the productivity of the expanded bed. In 
particular, the studies were based upon complex feedstocks, such as 
homogenates, to provide realistic challenges to the EBA system.
The systems under investigation were the recovery of Alcohol 
dehydrogenase (ADH) from Yeast via hydrophobic interaction 
chromatography and Glutathione S-Transferase (GST) from E. coli via 
anion exchange chromatography. The effect of the matrix particle size 
and operating velocity was conducted comparing these systems using the 
commercially available matrices STREAMLINE Phenyl and 
STREAMLINE DEAE. The use of prototype second generation anion 
exchange expanded bed matrices designed to operate at high feed 
velocities (300-600cm/hr) and high conductivity levels (20mS/cm) were 
also examined using the E. coli/GST system.
Scale-up and development work on the E. coli/GST  system led to a 
reproducible 5L fermentation producing 13mg/mL dry cell weight of E. 
coli with a corresponding GST concentration of 1.5mg/mL. The reaction 
time of the GST assay was successfully reduced from 5 to 1 minutes 
allowing quicker product analysis.
The effect of matrix particle size distribution and operating velocity on 
the recovery of ADH and GST using conventional EBA adsorbents was 
investigated. Conventional breakthrough curve analysis is not applicable 
to situations of variable particle size and operating velocity and in order 
to facilitate such studies a dimensionless experimental time group was 
developed based on the contact time in the column. This group allowed
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direct comparison of breakthrough curves from systems run at different 
flowrates and consisting of matrices formed from differing particle size.
For both systems it was found that at low operating velocities 
(lOOcm/hr), beds formed from smaller particles exhibited shallower 
breakthroughs than beds formed from larger particles. At the higher 
velocity (300cm/hr) typically utilised in EBA, the behaviour of beds 
formed from either small or large particles was comparable in terms of 
breakthrough behaviour. This was despite both systems being applied to 
different types of chromatography and dominant mode of binding -  HIC 
and surface area, and anion exchange and more complete bead 
penetration for ADH and GST respectively.
Various productivity definitions were assessed for their suitability in 
evaluating the processes investigated in this thesis, and was defined as 
the total product recovered per minute of processing time. It was found 
for both the ADH and GST systems that at the lower velocity of 
lOOcm/hr the beds made up of larger particles were more productive 
than the beds made up of small particles. However, the most productive 
option overall was the use of beds made up of smaller particles and 
operated at the higher velocity.
The second generation of expanded bed base matrix, named 
STREAMLINE Direct, is based on smaller but much denser matrix 
particles that can operate at higher velocities and as such should improve 
process productivity. The work in this thesis evaluated a selection of 
prototype multi-modal ligands that were coupled to the new 
STREAMLINE Direct base matrix.
The multi-modal ligands are anion exchangers that can tolerate 
conditions of high conductivity typical of many fermentation broths 
thereby allowing processing of undiluted homogenates and leading to 
further productivity improvements. The ligands presented for study were 
examined for their binding of bovine serum albumin (BSA) from buffer
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and GST from E. coli. Based on these studies, one ligand (DAB) was 
chosen to investigate the effect of conductivity on the binding of GST and 
to compare this performance with that of the commercially available 
STREAMLINE DEAE.
It was found that the STREAMLINE Direct DAB adsorbent performed 
consistently in the range of conductivity levels tested (3 -  20mS/cm) and 
its performance was comparable with that of STREAMLINE DEAE when 
operated at 10mS/ cm. Productivity with the STREAMLINE Direct DAB 
could be increased 5-fold as compared with STREAMLINE DEAE with 
no loss of yield or purity.
The work presented in this thesis provides a new method of 
breakthrough curve analysis that allows comparisons across a broad 
range of situations and thereby provides insight into the competing 
mechanisms that govern the rates and levels of adsorption. The thesis 
presents an analysis of the relative productivity of a range of systems and 
highlights the gains in terms of productivity to be achieved with the 
development of second-generation EBA multi-modal adsorbents. The 
thesis concludes with a summary of the potential areas of further study 
and an analysis of the commercial and regulatory aspects of EBA.
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The work carried out in thesis has presented many opportunities for 
further study. Areas to consider are listed below:
• The development of an improved elution protocol for both the 
Yeast/ADH and E. coli/GST  systems in order to recover close to 100% of 
the bound product, as this would improve productivities.
• A more thorough and detailed understanding of the impact of 
residence time on binding. It was observed that product binding and 
recovery only improved with increasing residence time up to a point 
beyond which additional residence time was not matched by a 
comparable rise in product bound.
• Costing of buffers, time and product in order to base the productivity 
expression on strictly economic grounds.
• Investigation into the effect of pH on GST binding to the prototype 
STREAMLINE Direct DAB. The purification of GST using this matrix was 
based on the protocol developed for STREAMLINE DEAE, however the 
effect of pH was not investigated and as such the purification of GST may 
be improved by such an investigation, thereby leading to gains in 
productivity.
• Integration of upstream  and downstream processing. As observed in 
this work, the binding of GST on STREAMLINE Direct DAB was 
prevented by some competitive entity, most likely some component of 
the fermentation media, in particular the yeast extract. By integrating 
fermentation development with that of the expanded bed step problems 
such as this could be avoided and provide a more complete analysis of 
the integrated process behaviour.
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• The increased understanding of binding kinetics based on particle size 
and operating velocity provided in this thesis may be of use in the field of 
expanded bed modelling.
The above considerations all relate directly to the work carried out in this 
thesis. More generally, with the trend towards M Ab/FAb products, 
development work utilising EBA and these types of products should be 
encouraged. Of particular interest would be to investigate whether 
expensive affinity processes utilising ProteinA matrix should be used 
early on in the downstream processing as is often practised, or whether it 
would be more beneficial to utilise an ion exchange EBA step followed by 
an affinity step of reduced size and hence costs. The productivity analysis 
methods developed in this work would provide a useful framework to 
commence such a study.
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ll.llntroduction
In an increasingly competitive environment, process economy is a key 
issue in the management of bioprocesses. Reducing the num ber of 
processing steps can lead to savings in operational cost and processing 
time and will improve the overall process yield.
Amersham Biosciences (now part of GE Healthcare) is a market leader in 
the production of expanded bed adsorption (EBA) matrices and columns, 
a unit operation that was designed to meet the above challenges. 
However, in order to remain in such a position, it is important that their 
products for this unit operation are able to keep up with advances in the 
field and customer requirements.
The work carried out in this chapter was part of an 8 month secondment 
to Amersham Biosciences during the Engineering Doctorate (EngD) and 
focussed on the research and development (R&D) project for a new 
generation of EBA matrices. For reasons of commercial sensitivity the 
specifics of the project are not considered, instead the structure and 
management of a general R&D project including descriptions of the 
various project phases are presented.
11.2Project Phase Definition
All Amersham Biosciences R&D projects consist of 6 phases which allow 
the project to be defined and developed with new products being 
launched based on proven technology, strategic relevance and potential 
profitability. Each phase of the project has various aims and objectives to 
be met and entry into the next phase must be approved by the Business 
Area Head.
146
Chapter 11: Bioprocess Project Management
11.2.1 Phase 0: Objectives
Aims: "To describe and initiate consideration of a product opportunity and to 
agree the resources needed to prepare a more detailed development proposal 
during Phase 1."
During this phase, marketing needs as proposed by the marketing 
department are described in a "project definition request" (PDR) 
document. This document outlines ideas for new projects that may be 
based on customer feedback or general industry developments.
11.2.2Phase 1: Definition
Aims: "For the Core Team first to confirm the business opportunities and 
available technology (if requested), to define the key requirements o f the product, 
and then to prepare project plans. These will be detailed enough to make 
commitments on delivery, and for the Business Area to evaluate consistency with 
strategic goals and profitability, in order for the Business Area Head to give their 
approval to continue."
An extensive business opportunity study provides forecasts and trends 
for the future, highlighting areas for potential growth and development 
that will complement the PDR from Phase 0. In addition the study will 
provide details around the specifics for the project in terms of 
deliverables. These will have been established from detailed customer 
surveys and from the business opportunity study. The available 
technology study will identify any possible complementary R&D projects 
and existing products that may be used in the project. As with all product 
launches, time to market is a key factor in maintaining market share and 
so at the outset of the project a realistic project timeline is established.
11.2.3Phase 2: Detailed Planning
Aims: "To build the complete project team, to clearly define the product 
specification and high level design, validate product implementation plans, and 
to prepare detailed project planning to confirm project commitments."
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The detailed planning phase will generally be based on the extensive 
studies carried out in Phase 1 and as such these 2 phases may be run  con­
currently as the deliverables defined in Phase 1 may be detailed enough 
for Phase 2. If not, then the deliverables will be defined in this Phase such 
that the next phase may be entered. It is also critical that the product does 
not impinge on any existing and current patents not belonging to 
Amersham Biosciences.
11.2.4Phase 3 Development
Aims: "Development and verification o f the product, development o f 
manufacturing processes and planning for availability and support."
Throughout this Phase (typically the longest), development of the 
product and any m anufacturing processes will be completed. Dependant 
on the specific project this may range in time from 1 year to 5 years. 
Decisions on the product in this Phase will be based on a num ber of 
criteria that will have been specified in the detailed planning but will 
include economics.
11.2.5 Phase 4: Market Readiness Preparation
Aim: " Preparing for availability, verification and validation of the product at the 
manufacturing scale and validation of the manufacturing processes. 
Continuation o f activities, started in 3, preparing for launch, product support 
and servicing."
The market readiness phase will typically be run con-currently to the 
development phase. The launch team, generally consisting of a number of 
departments including marketing, R&D, regional representatives and the 
project manager will begin to make preparations for the launch of the 
final product.
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A number of different areas such as pricing, marketing tools, name, in- 
house training etc have to be considered and as the project develops and 
the final product design comes closer to becoming a reality, there is a 
need to finalise decisions in order to be ready for product launch. It is 
also imperative that any literature that is prepared for marketing tools be 
approved by legal and regional departments.
Products typically have to be registered and so names must be carefully 
chosen such that they convey all aspects and selling points.
Product performance m ust be verified and validated. Application notes 
explaining when and how the product can be used in real life examples 
and situations are prepared. In order to produce consistent quality the 
production manufacturing process m ust also verified and validated.
Launch preparation discussions revolve around a number of areas. The 
product price is a crucial decision; too high and it would not be an 
attractive option to customers and too low and the company would stand 
to make losses if there were any problems for example with production. 
It is also important to be able to justify prices to customers by use of 
economic appraisals. Forecasts for post launch also have an impact on 
pricing decisions. It is imperative that these forecasts be as realistic as 
possible as ultimately, deviations from these forecasts could lead to 
changes in profit and loss (P&L) and could also lead to bad pricing 
decisions. Product marketing m ust also be considered.
11.2.6 Phase 5: Launch
Aim: "To support market introduction and volume manufacturing capability as 
well as evaluating the project performance and recommending follozv up 
activities."
Once all the previous Phases have been exited and the product officially 
launched, it is necessary to measure the success of the launch. Various 
success criteria are defined and the launch is measured against these.
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Achieving these goals would deem the project a success, however, if and 
when these goals are achieved, the launch phase is not over. This phase 
of the project is ongoing and should be viewed as a process that is 
continually reviewed and not as an end point or single activity.
11.3Discussion
Getting a product to m arket does not necessarily ensure its success or that 
of the company. The product may fail for a number of reasons such as 
poor design, lack of resource for continued support, no market need for 
the product, bad marketing etc. By clearly defining the various project 
phases for a new product development, risks to the firm can be 
minimised as projects can be terminated at early stages if they are not 
viewed as potential successes. Careful structuring of a project leads to 
successful products as all areas are considered before the product "hits 
the shelves".
The guidelines for an R&D project lead to higher chances of success as 
the structure ensures a team approach which leads to efficient 
communication between relevant departments, decisions being made in 
a timely manner and a final robust product. Overall, this should ensure 
that Amersham Biosciences maintain their dominant market position 
and reputation as a leading provider of bioseparation tools.
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12.1 Introduction
Validation is a process that industry must face in order to get products to 
market. Often, in the rush to market, validation may be sacrificed as it is 
seen as a costly and time consuming process. However it should be 
viewed as an opportunity to review comprehensively equipment and 
processes leading to an in-depth understanding of the process, thereby 
reducing product failures and variability. By planning validation into the 
process development, it is possible to design a robust process.
Validation is defined by the US Food and Drug Administration (FDA) as 
"Establishing documented evidence which provides a high degree of 
assurance that a specific process will consistently produce a product 
meeting its pre-determined specifications and quality attributes." (US 
FDA) Put simply, this means providing evidence that a process does 
what it should.
This chapter summarises the validation issues surrounding an expanded 
bed chromatography column and will consider how this should be 
validated as a unit operation in a whole process.
12.2General considerations
Whole process validation requires a careful consideration of many 
factors, such as raw materials, purchasing, facility design, air and water 
quality, equipment, change control, personnel training, maintenance 
programs and documentation requirements, amongst others.
The formulation of a Validation Master Plan (VMP) to cover all of the 
factors is to be encouraged. The VMP should consist of plans for 
execution of facility and equipment validation, covering installation, 
operational and performance qualification. The VMP should cover at
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which point in process development various tasks should be undertaken. 
For example, full validation of equipment and processes may not be done 
until Phase III and a graded approach is generally accepted by regulatory 
agencies although product equivalence must be demonstrated from one 
phase to the next.
It is im portant to note that any process changes, including increases in 
batch size (i.e. scale-up) requires validation of the change.
12.3Expanded Bed Adsorption Validation
To validate an EBA step in a process, there are a number of factors to 
consider. The equipm ent should be qualified, acceptance criteria for the 
raw materials and chromatography media should be defined, the process 
should be qualified and cleaning, sanitization and storage conditions 
validated.
12.3.1 Equipment Qualification
Equipment qualification consists of installation qualification (IQ) and 
operational qualification (OQ). IQ at its most basic definition ensures 
equipment is installed according to manufacturer's recommendations. 
The OQ tests that that column functions properly by running the 
equipment with a sample.
For an EBA column, the IQ and OQ confirm that each component of the 
system meets design criteria, including any valves and pumps associated 
with the column. For packed beds, the OQ would involve testing the 
symmetry of the packed bed column (Sofer and Hagel, 1997), however 
this is not applicable to an EBA unit. As such the OQ would utilise a 
tracer molecule, such as acetone, to test for residence time and to measure 
bed expansion (Sofer, 1999).
If the system is automated then IQ and OQ should also be performed for 
both hardware and software.
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12.3.2 Raw Materials
For those raw  materials that are purchased, such as buffer ingredients 
and chromatography media, vendors should be audited and certified in 
order to reduce the chance of variability. For chromatography media, 
vendors will typically supply certificates of analysis and regulatory 
support files (RSF). Whilst this type of file reduces the quantity of testing 
performed by the end user, it is imperative that acceptance criteria are 
defined such as identity testing (usually visual inspection of the media 
and packing/label inspection) and small scale function testing related to 
the application.
Another key criteria particularly for chromatographic media is the issue 
of leachables. All chrom atography media leak and therefore it is 
necessary to determine where in the process leakage occurs and to 
specify what level of leakage is acceptable. Particularly for new media 
such as the second generation matrices investigated in this thesis where 
little data is available, leakage studies would be absolutely crucial. In 
order to test leakage, exposure of the media to extreme pH values 
followed by identification of any leakage products and quantification of 
these leakage products in the eluate would be advisable.
For those raw  materials that are not purchased, such as feedstream, 
acceptance criteria would typically be defined to include a range of 
parameters such as total protein, total product, viscosity and 
conductivity. As demonstrated in this thesis, when employing ion 
exchange chromatography, conductivity is a key parameter. Viscosity in 
expanded beds is also crucial as it affects the overall degree of expansion 
which can lead to variability in the residence time, also a key factor in 
product binding.
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12.3.3 Process Qualification
Process qualification is aimed at ensuring process consistency. Process 
performance can be defined in terms of a number of parameters, such as 
yield and purity of product which m ust be reproducible within a defined 
range. Generally parameters that are validated during the process 
performance qualification are defined within broad ranges during the 
development stages of a process. As understanding of the process is 
gained through experience, the ranges are narrowed.
To prove the process is consistent, consecutive batches at full or pilot 
scale are run. In the USA, this is typically a minimum of three batches; in 
Europe five batches are required.
12.3.4 Cleaning, Sanitization and Storage
Cleaning validation is a critical issue in validation. Whilst it is the case 
that media is utilised for one product, the equipment may be used for 
multiple products and therefore it is essential that any cleaning validation 
can demonstrate the absence of carry-over through the use of product 
specific assays and general assays such as total organic carbon (TOC) and 
total protein.
EBA columns can be completely dismantled and therefore thorough 
cleaning and sanitization is possible, however, standard operating 
procedures (SOP's) m ust be developed that are easy to follow and 
removal of cleaning agents and detergents must be demonstrated.
Cleaning of the chromatography media is also crucial, especially due to 
the nature of the matrix in the sense that its porous structure may lead to 
potential contaminants that are difficult to detect. When carrying out 
cleaning studies for media it is common that the media lifetime is 
investigated concurrently. This is preferably carried out using actual 
product feedstream but standard proteins such as lysozyme or BSA may
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also be used to investigate the effect of clean-in-place (CIP) procedures on 
the dynamic capacity after multiple cycles.
Storage of media and columns m ust be able to demonstrate that storage 
solutions prevent microbial growth and can be fully removed. Labelling 
of "clean" and "dirty" columns and media also form part of the storage 
validation.
12.4Conclusions
Validation is a necessary part of product development and it builds 
consumer confidence as it provides documented evidence that a process 
does what it should. Validation that is carried out early on in the 
development highlights potential failures thereby allowing the 
development of preventative measures and building a robust process.
Although products cannot be released without approval from regulatory 
bodies, validation should not cease once a product is on the market as 
regulatory bodies expect bioprocessing firms to remain up to date with 
new technology and guidelines.
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A ppen d ix  I -  Fl u id isa t io n  Theory
Introduction
Fluidisation is the process whereby a continuous stream of fluid (gas or 
liquid) is allowed to pass through a bed of solid particles, w ith the 
separation of the particles caused by the fluid flow itself. Fluidised 
reactors and beds have been used in many applications in the chemical 
industry for well over half a century, and their use is well documented in 
such applications as catalytic cracking (where a stream of hydrocarbon 
gas is allowed to contact a solid catalyst to force a splitting reaction 
creating smaller molecules). This is one example of gas-solid fluidisation. 
However, the less common (at least in the chemical industry) process of 
liquid-solid fluidisation is the basis of this research. In the field of 
Biotechnology, chromatographic separations have been successfully 
carried out using expanded beds, and a dedicated series of 
chromatography columns and matrices are available from Amersham 
Biosciences (STREAMLINE components) solely for expanded bed 
operations.
Fluidisation theory for liquid-solid systems
Liquid can flow either up  or down through a bed packed with solid 
particles. In term of fluidisation, flow downward through a bed is of little 
interest since the bed cannot become fluidised in this state. However flow 
downwards in the bed is im portant for other reasons and will be 
discussed elsewhere.
When liquid flows upw ards through the bed, pressure drop from along 
the length of the bed will be directly proportional to the flowrate of the 
liquid at low flowrates, and the bed remains in a "packed" configuration. 
However as flowrate increases, and the apparent weight of the particles 
becomes equal to the frictional drag exerted on them by the fluid flow
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(the apparent weight is the actual weight of the particle minus the 
buoyancy of the particle in the liquid concerned) then the particles begin 
to move and rearrange themselves so as to offer less resistance to liquid 
flow - the bed is beginning to expand. This point is known as the 
fluidising point. This process continues with increasing liquid flowrate 
until the particles reach the state where they are offering the least 
possible resistance to fluid flow. This is the situation where the pressure 
drop is highest, since further increases in liquid flow result in the 
particles becoming further separated, but since the resistance to flow 
remains approximately the same so does the pressure drop. At this stage 
the bed is said to be fluidised.
In the fluidisation of a particulate bed, it is vital that the fluidisation is as 
good as possible (free of channelling, regions of backmixing, etc.). This is 
achieved w ith plug flow of liquid through the bed. This is very difficult 
with a bed of solid particles, especially if the are of irregular shapes, or if 
they aggregate easily. Hence the study of flow patterns is im portant to 
achieve good fluidisation.
By plotting log AP (pressure drop along column) against log U 
(superficial liquid velocity) as shown in figure AI.l the effects described 
above are shown graphically. Log AP increases linearly until the point A 
(the fluidising point). The pressure drop continues to increase until it 
reaches a maximum (point B) before falling slightly and becoming 
independent of superficial velocity and hence independent of flowrate 
(region CD). Note that if velocity were reduced again the pressure drop 
would remain constant until the particles were just touching one another 
(point E - the point of maximum stable porosity for a fixed bed). The bed 
would in theory remain in this state as flowrate was further lowered but 
in practice any external vibrations would cause particle rearrangement 
and a return to the line OA rather then the theoretical line EF, with lower 
pressure drop for a given superficial velocity.
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Fixed bed C Fluidised bed D
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log U
Figure AI.l: Illustration of different stages of particle fluidisation.
In order to relate the pressure drop to the difference in density of the 
solid and liquid phases, it is necessary to perform an unsteady state 
momentum balance. Given that a fluidised bed can be assumed to be a 
two phase closed system, bounded by the bottom of the bed vessel (plane 
b) and the upper surface of the particles (plane t) then a momentum 
balance, after converting vectors to scalars for simplicity, yields:
j j  P„ = Pf, («/ )s -  p f i {uf)s + p„S -  p ,S  -  F -  mg (AI.l)
In the above expression, Ptot is the total momentum of the system, S is the 
cross sectional area of the column and u is the local velocity at any given 
point. The terms on the right hand side of the system represent, 
respectively, the rate of m om entum  into the system by bulk motion, the 
rate of m omentum  leaving the system by bulk motion and the pressure 
forces exerted on the system by the bottom and top planes. F is the force 
exerted by the surfaces of the solid in the system on the liquid and mg is 
the force on the liquid due to gravity. Since in an expanded bed of solid 
particles, the surface area of particles is generally much greater than the 
internal surface area of the containing column then the latter can be 
neglected hence F is the force exerted by the surface area of the entrained 
particles only, and is therefore equal to the weight of these particles.
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F = { \-e )S H p sg  (AI.2)
Where H  is the height of the bed and e is the voidage, or the fraction of 
liquid contained in the bed. At steady stated / dt(Ptol) = 0
Assuming constant velocity profiles across the bed, and that the liquid in 
the system is effectively incompressible, p fb = p f  and ( ^ )  = (wj2)
The force acting on the fluid due to gravity, mg, can be converted to a 
more manageable form by replacing the mass term thus mg = epf SHg
If all these terms are substituted into the fundamental momentum 
balance it becomes
(e -  1 )H psg -  epf Hg = p, -  pb (AI.3)
Now defining P  = p -  p f gh where h is distance to any plane (so if h is
distance to plane t then (H-h) is distance to plane b) then by substitution 
and rearrangement,
- A P  = / > _ / > = ( , _ e)(Pi _ p . ) Hg (AI.4)
This expression holds while the bed is in the fluidised regime.
Minimum fluidisation velocity
As the upw ard flow of liquid through a packed bed of uniformly shaped 
particles increases, a certain point is reached when the particles are just 
freely supported in the liquid. This is known as the point of incipient 
fluidisation. At this point a corresponding minimum fluidisation velocity 
umf  can be calculated based on the Carman-Kozeny equation for the 
voidage in a fixed bed. This equation is only valid given STREAMLINE 
flow in a bed packed w ith uniform spheres of diameter d, but these are 
the conditions that apply in a well-packed expanded bed utilising a 
standard beaded matrix. The Carman-Kozeny equation is based on the 
theory that the pressure drop in a fixed bed is equal to the buoyant
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weight of the solid particles supported in it. This holds until the 
transition to fluidisation.
The equation below is obtained when the voidage at the point of incipient 
fluidisation (em/) is substituted into the Carman-Kozeny equation:
n n n c c  ^  /  a  t  c \umf = 0.0055---- -------- ----------- — (AI.5)
1 -  emf V
Although the voidage at the point of incipient fluidisation depends a 
great deal on the particle size, shape and even density, for uniform 
spherical particles it w ould be assumed to be about 0.4. Thus substituting 
this into the above equation:
K / L /=o, = 0 . 0 0 0 5 9 ^ - ^  (AI.6)
Under some conditions, such as when the particles are too large for 
STREAMLINE flow to take place at the point of fluidisation, a more 
general equation based on the pressure gradient in the bed (for example 
the Ergun equation):
150^  e ) + 1.75 P/Umf (AI.7)
/ e3 d 2 e3 d  y ’
Thus by substituting e = emf at the point of incipient fluidisation and -A P  
from equation (AI.4) the equation can be expressed in terms of umf :
( \ - e m/)(ps - p f ) g = l 5 0 ^ ^ -  ^ f  + 1.75i L ^ l ^  (AI.8)
e mf  61 e mf a
p f d 3
Then by multiplying both sides by ——(-------- r to express the equation in
P  ( l ~ e mf )
terms of dimensionless numbers:
P f ( P s  - P f ) g d 3 i - y  umf d p f  1.75f umfdpY
P~ *tf  P  e l f P 7
(AI.9)
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In this equation several dimensionless numbers can be inserted for ease
d 3 P f \ P s — p  f )g
of expression. For instance, -------  —----- is the Galileo number Ga,
P
umfd p f
and   is a modified form of the Reynolds number and in this case
P
will be designated the Reynolds number at minimum fluidisation 
velocity or Remf.
This allows equation (AI.9) above to be simplified to:
Ga = 1 5 0 ^ * -  Remf + ^  Re2m/ ( A L I O )
e mf  e mf
Since by definition u f = ^  Remf, and the voidage at minimum
d p f
fluidisation can be predicted or measured, then the minimum fluidising 
velocity for a given system can be obtained.
Models for describing bed expansion
It is im portant to consider the behaviour of the individual particles 
within an expanded bed as a route to predicting the behaviour of the 
whole bed. To this aim, this section introduces published mathematical 
models for describing bed behaviour.
There are two main m ethods for describing the behaviour of a bed of 
particles during fluidisation. In general liquid-solid fluidised systems are 
characterised by the regular expansion of the bed as velocity increases 
above the m inim um  fluidising velocity (but below terminal particle 
falling velocity). The general relationship between liquid linear velocity 
and voidage is very similar to the relationship between sedimentation 
velocity and particle volumetric concentration in a solid-liquid 
suspension. This is perhaps not too surprising as the systems are 
hydrodynamically very similar, with the "stationary" phase being the 
solid particles in the case of an expanded bed and the liquid in the case of
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a suspension. The utilisation of this fact in a model to predict behaviour 
was first postulated by Wilhelm and Kwauk (1948) and further 
developed by Richardson and Zaki (1954) and was dubbed "the cell 
model" as it treats one particle as being limited to movement within a 
fixed cell. The cell is taken to consist of two concentric spheres, the radius 
of the inner being that of the particle. It was noted by these workers that:
= e" (A I.ll)
Where uc is the fluidisation velocity, w, is the corresponding velocity at 
infinite dilution, e is the voidage and n is an index. This was seen by 
plotting particle Reynolds num ber against bed voidage over a range of 
conditions during fluidisation. Values of n were found to range from 2.4 
to 4.8 and can be found for known Galileo number Ga given the 
expression
48 = 0.043Ga
n — 2.4
Although the conditions are similar for both sedimentation and 
fluidisation, Richardson and Zaki found that while ut and u0 (free 
settling velocity of a particle in infinite medium) are very similar for 
sedimentation they were found to vary in fluidisation and proposed the 
following equation:
logio “o = *ogio « i +  - J -  (AI.13)
d,
Since d/dt is the ratio of particle diameter to tank diameter, it would in all 
probability be very small in a sedimentation tank but may be significant 
in a fluidised column. This is believed to account for the difference noted 
by Richardson and Zaki. More recently modifications of the above 
correlation have been developed (Khan and Richardson (1989)) to allow 
for the influence of the walls of the vessel during fluidisation. When
1-1.24
( d
\ d t j
(AI.12)
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voidage is plotted against superficial liquid velocity on logarithmic co­
ordinates, the voidage remains constant at low flowrates (fixed bed 
regime) and then increases in a linear fashion with velocity (fluidised 
regime).
The second and more widely used model is based on viewing the bed as 
a series of bundles of tangled tubes for fluid flow. If these tubes could be 
viewed as individual straight tubes, then the bed could be modelled 
based on this. Based on a derivation of the Hagen-Poiseulle equation but 
replacing the m ean tube velocity u  in the equation with the interstitial 
velocity u /e  and the tube diameter with the hydraulic diameter D h  gives 
the following modified version of the Hagen-Poiseulle equation:
2( 36) / ju H (1 -  e)' 
~dre :AP = V ,2 ,-----   (AI.14)
This model is however flawed slightly as it would be erroneous to 
assume that the bed consists of straight-pathed tubes as modelled by the 
above equation. In order to take account of this the value 2 at the start of 
the equation is replaced w ith the value 25/6. This results in the Blake- 
Kozeny equation. The modification of the value 2 is known as the 
tortuosity factor r where:
a v e r a g e  p a th  len g th  /AT1CN-j- _ —— (AI.15)
b e d  h e ig h t
This model can be used to predict the behaviours of both fluidised and 
fixed beds, but it m ust be noted that the tortuosity varies for fluidised 
beds but remains constant for fixed beds. A completely fluidised bed will 
have a tortuosity value of approaching unity.
Effect of particle size distribution on fluidisation 
velocity
In general it can be assumed that, if the particles being fluidised have a 
uniform size then the transition between fixed and fluidised bed will be
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categorised by a discrete step on the pressure drop-liquid velocity curve 
(Figure AI.l). However as the distribution of particle sizes becomes more 
spread, the transition tends more towards a smooth curve, thus creating 
three discrete regions on the pressure drop-fluidisation curve; the fixed 
bed region, the fully fluidised region and a transition region separating 
the two. In this case there is no specific minimum fluidising velocity, but 
a small range of velocities from the velocity at the onset of fluidisation 
(often known as ubf) and the velocity at which the bed is totally fluidised
(known as utf). In this case the value for minimum fluidisation velocity
must be approxim ated, and can be obtained from equations such as 
(AI.14) using a m ean particle diameter value (often approximated to 
diameter at 50% total frequency on a particle diameter vs. frequency plot) 
so long as the value for the voidage at minimum fluidisation velocity is 
known. This can usually be approximated to emf = 0.4 although Wen and
Yu (1966) found that emf = 0.42 gave improved bed stability.
Effect of particle size distribution on voidage
In a fluidised bed w ith uniform  sized particles, uniform voidage would 
also be expected. How ever in the case of a bed with a size distribution, 
the particles will segregate according to their terminal falling velocity in 
the fluid, and as such the voidage will vary along the length of the bed as 
the particles are segregated. This presents problems with respect to 
system modelling since the void fraction is variable with height in the 
bed.
This problem has been considered by Wen and Yu (1966) who studied
, . .. . . largest particle size , „ .binary systems and stated that, if the ratio -------------------------<1.3 then
smallest particle size
all particles would form a single layer in the system. Thus the expansion 
characteristics of the bed could be defined by equation (AI.l6) below 
where the particle diameter is replaced by an equivalent:
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e 47 d g j P *  ~ P f ) P f = 18Re+ 2.7Re1687 (AI.16)
Under the conditions 0.01 < Re< 1000 for the system studied (water) and 
where d  = d e as defined:
Where x, is the fraction of the total weight of the particles of all particles 
with diameter d t . In the case of particle size distributions larger than 
those covered by the above equations, the particles were seen to 
segregate and the voidage could be determined by summing the voidage 
of individual layers of the system.
(AI.l 7)
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